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The proportion of patients over 75 years of age, receiving all different types of 
healthcare, is constantly increasing. The elderly undergo surgery and anaesthetic 
procedures more often than middle-aged patients. Therefore, clinical trials in the 
older category of patients will be needed to facilitate improvements in health care 
methods. Pain is commonly underestimated in the elderly during the postopera-
tive period and also during rehabilitation in the geriatric department of a primary 
care hospital. Pain management should be based on regular pain assessment with 
easily applicable and validated pain measurement tools. The aim of this study was 
to investigate pain measurement and management in cognitively impaired patients 
in long term hospital care and in cognitively normal elderly patients after cardiac 
surgery.
Studies I-V incorporated 366 patients, including 86 home-dwelling or hospi-
talized elderly (I-II) and 280 patients undergoing cardiac surgery (studies III-V). 
Patients suffered from chronic pain (studies I-II) or acute pain (studies III-V). Pain 
intensity was measured with the Verbal Rating Scale (VRS) (study I-V), the Visual 
Analogue Scale (VAS) (study I-III), the Red Wedge Scale (RWS) (study II-IV), and 
the Facial Pain Scale (FPS) (studies II-III). Cognitive function was assessed with 
the mini-mental-state examination (MMSE, 0 to 30) (studies I-II, V), depression 
with the Geriatric Depression Scale (GDS, 0 to 15) (studies I-II), and functional 
ability in daily life assessed with the Barthel Index (0 to 100) (study I). Postopera-
tive sedation was assessed with the Ramsay sedation scale (study IV) and with the 
Richmond Agitation Sedation Score (RASS) (study V). The degree of postoperative 
confusion was measured with the modified Confusion Assessment Method for the 
ICU (CAM-ICU, 0 to 25) test (study V).
The effects and plasma concentrations of fentanyl and oxycodone were measured 
in elderly (≥ 75 years, n=30) and middle-aged patients (≤ 60 years, n=20) after 
cardiac surgery (study IV). Fentanyl plasma concentrations were measured at the 
end of surgery and two hours later. The blood samples for fentanyl and oxycodone 
plasma concentrations measurements were taken after tracheal extubation, when 
a threshold of pain intensity was reached (VRS ≥ 2). Thereafter, an intravenous 
0.05 mg/kg dose of oxycodone was administered. Oxycodone plasma concentration, 
pain intensity, and the degree of sedation were determined 15 and 45 min after the 
oxycodone dose. This protocol was repeated twice in study IV.
The opioid-sparing effect of pregabalin was studied after cardiac surgery in el-
derly patients (≥ 75 years, n=70) whom were randomized to receive either placebo 
or pregabalin (150 mg) preoperatively  followed by either placebo or pregabalin (75 
16
mg) twice daily postoperatively (study V). When the pain intensity was elevated 
(VRS ≥ 2), patients received oxycodone either intravenously (0.05 mg/kg) or orally 
(0.10-0.15 mg/kg). Postoperative pain was assessed using the VRS, by a telephone 
interview, both one and three months after operation.
The mean age of patients was 77 (SD ± 8) years and 8364 pain measurements 
were performed with four pain scales in elderly patients (studies I-V). All pain 
scale measurements correlated positively with each other at rest and during mo-
vement (studies I-III). The Barthel Index correlated positively with MMSE scores 
(r = 0.367, P < 0.05) and negatively with GDS (r = -0.176, P < 0.05), but has no 
constant negative correlation with pain scores in study I. Patients with an MMSE 
more than 24, were able to use all four pain scales rather successfully. The VRS 
was most successful in the groups of demented patients (MMSE 17-23, 11-16 and 
≤ 10) and in elderly patients (≥ 75 years) on the first day after cardiac surgery 
(study II-III). Success rates improved for all scales during the four postoperative 
days after cardiac surgery (study IV). The elderly had a higher plasma concentra-
tion of fentanyl at the end of cardiac surgery than younger (≤ 60 years) patients 
(P = 0.001). The plasma concentrations of oxycodone were comparable between 
the groups. Pain intensity on the VRS was lower at the 45 min assessment point 
after all three oxycodone tests doses (P = 0.008) and the sedation scores were 
significantly higher after the third dose of oxycodone in the elderly (P = 0.035) 
(study IV). Total oxycodone consumption from extubation to the end of the fifth 
postoperative day was reduced by 48% in the pregabalin group (P < 0.05; study 
V). The CAM-ICU scores were significantly lower on the first postoperative day in 
the placebo group (P < 0.05). There was no significant difference with respect to 
the MMSE scores or the RASS scores between the pregabalin and placebo groups. 
The incidence of postoperative pain during movement was significantly lower in 
the pregabalin group 3 months after surgery.
This investigation demonstrates that chronic pain did not seem to impair daily 
activities as much as cognitive dysfunction and depression in home-dwelling Finnish 
elderly people. The VRS appeared to be applicable for elderly patients with clear 
cognitive dysfunction (MMSE<17) and it was the most feasible pain scale for the early 
postoperative period after cardiac surgery. After cardiac surgery, elderly fentanyl 
plasma concentrations were elevated, although plasma oxycodone concentrations 
were at a similar level compared to middle-aged patients. The elderly had less pain 
and were more sedated after doses of oxycodone. The administration of pregabalin 
reduced postoperative oxycodone consumption after cardiac surgery. Pregabalin-
treated patients had less confusion, in addition to less early postoperative pain on 




Pain may often be underrecognized and inadequately managed in the elderly. 
Previous studies have demonstrated that 25 to 50% of community-dwelling elderly 
report pain that interferes with daily life (Higgins et al. 2004; Thomas et al. 2004). 
Pain incidence rates of 45 to 80% have been reported for patients in long-term care 
facilities (Ferrell et al. 1990; Ferrell et al. 1995), although a study by Finne-Soveri 
and colleagues reported that 22 to 24% of residents experienced daily observable 
pain and this was most evident in the more disabled subjects (Finne-Soveri et al. 
2000). Many studies have also documented an unacceptable prevalence of poor 
pain control after surgery (van den Bosch et al. 2006).  Poorly controlled and acute 
pain can be severe, which can increase the risk of a chronic pain state (Bruce et al. 
2003). Despite the fact that the measurement of pain intensity is difficult because 
it is multifaceted including affective, cognitive, physical, sensory, behavioral, social 
and cultural factors (McGuire 1992), pain measurement remains a critical first 
step to deliver effective and adequate pain management. Pain assessment in the 
elderly should start with self-reported pain, but also nonverbal pain behaviors 
should be evaluated among individuals with severe dementia or other conditions 
that impair communication (Fuchs-Lacelle and Hadjistavropoulos 2004; Fuchs-
Lacelle et al. 2008).
Pain relief after surgery and for chronic pain can be improved by the routine 
assessment of pain intensity, and by the routine use of simple validated pain me-
asurement scales for the elderly (Ferrell et al. 1995; Breivik and Stubhaug 2008; 
Breivik et al. 2008). The ability to achieve effective pain control with minimal ad-
verse effects from analgesics is desirable in the elderly; there is a need for impro-
ved methods of assessing pain in older adults, especially those with postoperative 
confusion, cognitive impairment or dementia.
Opioids are the main drugs chosen to treat moderate to severe postoperative 
and chronic pain (Kalso 2005a; Wilder-Smith 2005; Breivik and Stubhaug 2008). 
Although the opioid dose should be individually tailored relative to the pain me-
asured and serious side-effects like respiratory depression, sedation, and nausea 
are common problems in elderly pain management. 
Therefore, new pain treatment strategies are needed for elderly patients. Multi-
modal analgesia has an important role for optimal pain treatment; it may decrease 
opioid consumption and also reduce opioid-related side-effects. Pregabalin is an 
anti-epileptic drug that has demonstrated anti-hyperalgesic properties in human 
pain models (Chizh et al. 2007). Pregabalin may be a useful drug for multimodal 
analgesia in pain management after cardiac surgery and in chronic pain in the el-
18
derly (Guay 2005; Tiippana et al. 2007; Gilron 2007).
The purpose of the present study was to evaluate pain assessment and to improve 
pain control in demented older adults in long-term hospital care and cognitively 
normal elderly patients after cardiac surgery. The goal was to investigate effects 
and plasma concentrations of fentanyl and oxycodone and the use of pregabalin 
for pain management after cardiac surgery.
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5. reVieW oF tHe literature
Western countries, and indeed most parts of the developed world, have accepted 
that reaching the retirement age of 65 years defines someone as an elderly person. 
However, the age of 65 is often the beginning of old age in Finland and the clas-
sifications by age provide no information about a person´s health and physical 
condition. Elderly patients can be generally classified into a younger (age 65-75) 
and an older group (age 75 and over).  The percentage of elderly aged 75 and over 
that receives institutional care or housing services for elderly was only at 10 per cent 
of the corressponding age group. There were 255 912 persons aged 80 and over in 
Finland´s population (5, 37 million) at the end of 2010. The number has increased 
five-fold over the last 40 years (Finland). According to the Official Statistics of 
Finland, 42 802 persons lived in residential homes for older people and sheltered 
housing units with 24-hour assistance at the end of 2009, where the average age 
was 83.7 years (National Institute for Health and Welfare 25/2010). The number 
of elderly surgical patients will be expected to increase to approximately 5.2% of 
the Finnish population by 2020. The majority of surgical procedures are performed 
in the elderly, whose function and better quality of life have improved significantly 
along with the advances in surgical technology and techniques. 
5.1. aCute pain in the elderly
The relationship between ageing and postoperative pain remains unclear despite a 
number of investigations. Many studies have suggested that elderly patients report 
lower pain intensity than younger patients (Bisgaard et al. 2001; Kalkman et al. 
2003), whereas the others have not found age differences (Gagliese et al. 2000; 
Morin et al. 2000). However, even with developments in methods for assessing 
pain, elderly patients´ postoperative pain is often undertreated (Feldt et al. 1998; 
Aubrun et al. 2003; Aubrun and Marmion 2007; Breivik and Stubhaug 2008). 
Moreover, cognitively impaired older patients receive significantly less analgesics 
than cognitively intact elders undergoing similar painful surgical procedures (Mor-
rison and Siu 2000), although there is no clinical evidence that cognitive impairment 
is associated with decreased pain intensity or sense (Gibson and Helme 2001). The 
studies of pain assessment and management practices for elderly patients with 
hip fractures admitted to acute care settings show that pain in this population still 
continues to be undermeasured and undertreated (Ardery et al. 2003a; Titler et al. 
2003; Herr et al. 2004;). High postoperative pain intensities and undermedication 
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in the elderly are associated with postoperative pulmonary complications, postop-
erative confusion and delirium, increased hospital length of stay, and long-term 
functional impairment (Feldt and Oh 2000; Shea et al. 2002). Postoperative pain 
may cause suboptimal mobilization and medical complications because of immobil-
ity. Cardiovascular consequences of unrelieved pain include increased heart rate, 
blood pressure, and myocardial oxygen demand with an increased risk of myocardial 
infarction. The severity of perioperative and postoperative pain can also influence 
the development of postsurgical chronic pain syndromes such as sternotomy pain 
(Bruce et al. 2003; Lahtinen et al. 2006). 
Numerous guidelines have been published relating to the management of posto-
perative pain. The Agency for Health Care Policy and Research (AHCPR) pioneered 
the education of caregivers, followed by the American Pain Society and the Ame-
rican Society of Anesthesia. More recently, the Joint Commission Accreditation of 
Healthcare Organizations (JCAHO) has published “Standards for Pain Management 
in Hospital Settings” that were implemented 2001. 
5.2. ChroniC pain in the elderly
Chronic pain has been traditionally defined by pain duration, but this approach has 
limited empirical support. Chronic pain continues past the normal duration of tis-
sue damage, that is usually more than 3-6 months (Gagliese and Melzack 1997). It 
can lead to functional loss, reduced daily activity and reduced quality of life, which 
in turn can also cause mood and behavior changes. Chronic postoperative pain is 
evident for one in ten surgical patients, developing to be an intolerable, CRPS-like, 
chronic pain condition after one of every hundred operations, irrespective of  the 
type of surgery (Kehlet et al. 2006). 
Chronic pain is very common and often underestimated and undertreated in the 
elderly, especially among old people living in nursing homes. Many studies show 
that 25 to 50% of older patients experience clinically relevant pain, and among 
nursing home residents the prevalence is 45 to 85%. Other studies show that about 
80% of older patients suffer from a chronic disease typically associated with pain 
(Finne-Soveri and Tilvis 1998a; Won et al. 2004; AGS Panel on Persistent Pain in 
Older Persons 2002; Achterberg et al. 2010). Nevertheless, chronic pain is still rarely 
evaluated among nursing home residents and hospital patients, perhaps because 
of the common belief that aging and pain are conversely linked together. Conse-
quently, depression, sleep disorders, anxiety, cognitive dysfunction, malnutrition, 
slow response to rehabilitation therapy, and immobility, which are common in the 
elderly, can be influenced by pain (Gallagher et al. 2000; Gloth 2000; Edwards et 
al. 2003). Chronic pain associates too often with surgery and the poor treatment 
of acute pain in the elderly (Won et al. 2004).
21
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Neuropathic pain is a common type of chronic pain that is caused by pathology 
in the peripheral or central nervous system such as neuropathies, postherpetic and 
trigeminal neuralgias, and cerebrovascular strokes (Dworkin 2002; Jensen 2002). 
Neuropathic pain is highly diffuse, has a low response to analgesics, and is difficult 
to treat. A study from 68 United Kingdom nursing homes found a 37% prevalence of 
chronic non-cancer pain and a 2% prevalence of chronic cancer pain. Neuropathic 
pain is common in the elderly and its occurrence can be related to complex factors. 
A large number of factors and medical conditions are commonly associated with 
pain in long-term care residents (Ferrell et al. 1995; Allcock et al. 2002). In most 
cases, pain among the elderly is a common experience that is often characterized 
by the concomitant presence of different types of varying diseases and causes of 
pain at multiple locations.
5.3. assessment of pain in elderly patients 
The assessment of older patients experiencing pain can be a challenging process in 
the different stages of clinical practice. The assessment of acute pain should be a 
simple and fast task for all patients, whilst the assessment of chronic pain presents 
a more demanding task (Herr and Garand 2001; Gagliese and Katz 2003; Rakel 
and Herr 2004). The assessment of chronic pain conditions requires pain history, 
physical examination, and specific diagnostic tests. The pain history must indicate 
location, intensity, pain descriptors, temporal aspects, pathophysiological and a 
etiological issues and the type of pain involved (nociceptive, neuropathic). Therefore, 
a comprehensive medical history is an important part of the pain history, including 
the consideration of reasons for a complex pain condition (Gagliese and Melzack 
1997 Gallagher et al. 2000; Breivik et al. 2008).
An Interdisciplinary Expert Consensus Statement on Assessment of Pain in Older 
Persons (Hadjistavropoulos et al. 2007) is intended to provide recommendations 
that will be useful for both researchers and clinicians. Self-report pain assessment 
procedures have been accepted as the most reliable source of information on older 
patient’s pain unless the patient has serious limitations in their ability to communi-
cate. The majority of older patients are able to make a self–report regarding pain. 
However, it is not only important to allow the patient to have sufficient time to con-
sider the questions and formulate answers, but also to explore different words that 
elderly patients may use synonymously with pain such as “ache,”, “soreness,” “bot-
her” or “hurting”. Pain assessment recommendations for older adults are presented 
in Table 1 by Rakel and Herr 2004. The assessment of chronic pain and the effects 
of treatment remain more challenging in patients suffering pain from non-cancer 
causes. Also many older patients suffer from both acute and chronic components 
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of pain in tandem, making it difficult to find a suitable, valid and reliable pain me-
asurement tool in clinical practice. As with chronic pain, the assessment of acute 
pain should include an appropriate pain history, including the evaluation of pain 
intensity, location, character, and recent changes (Hadjistavropoulos et al. 2007). 
table 1. summary of pain assessment recommendations for older adults  
(Rakel and Herr 2004)
1. Consider obvious sources of pain, including incisions, trauma, 
positioning, irritating infusions, and recent surgery.
 Consider the elder’s history and potential chronic conditions that could 
be contributing to pain.
2. Attempt to obtain self-report of pain presence and pain intensity.
 Use simple questions and adapted instruments appropriate for elders and 
those with cognitive impairment.
3. For elders unable to self-report, use behavioral observations (both typical 
and less obvious) and physiologic indicators to support a suspicion of 
pain.
4. Use family members’ or other caregivers’ knowledge of the elder’s 
baseline behaviour to identify changes in behavior or activities suggestive 
of pain.
5. Consider giving an analgesic dose and observe for changes in behaviour to 
validate suspicion of pain.
6. Systematically assess and document at regular intervals and after 
interventions have had time to take effect.
7. Use the same pain scale or behavioural approaches each time pain is 
assessed.
8. Record pain assessment data in accessible location available to all health 
providers involved in the elder´s care.
5.3.1. problems with adequate assessment in the elderly
Many elderly people consider pain to be a normal part of aging. Furthermore, older 
patients may view pain as a normal part of surgical procedures as will some of their 
caregivers (McCarberg 2005). Reporting of pain can be influenced by cultural, 
social, physiological and psychological changes associated with aging. Addition-
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ally, anxiety, fear, depression, cognitive impairment, confusion and postoperative 
delirium, dealing with the implications of disease, loss of independence, and feelings 
of isolation may all impact on the experience of the pain intensity (AGS Panel on 
Persistent Pain in Older Persons 2002; Davis and Srivastava 2003). 
5.3.2. doCumenting pain
The patient is the best and only reliable source for pain assessment (AGS Panel on 
Persistent Pain in Older Persons 2002; Brummett CM and Hasset AL 2011; Gilron 
I and Jensen MP 2011). If the patient is able to verbally communicate, they may 
provide a description of the quality, location and nature of the pain, in addition to 
factors that impact on pain relief or exacerbation. Cognitive impairment reduces the 
relative volume of reports of pain intensity and general pain complaints (Parmelee 
et al. 1993; Farrell et al. 1996; Parmelee 1996; Herr et al. 2006a).
5.3.3. pain intensity measurement tools for the elderly
There is no universal pain assessment scale that is suitable for all older patients. 
However, pain assessment tools for younger patients are also likely to work in the 
elderly, even in those patients with mild or moderate cognitive impairment (Ferrell 
1995; Bergh et al. 2000; Freedman and Peruvemba 2000). 
5.3.3.1. Verbal Rating Scales (Figure 2, Table 2)
Verbal Descriptor Scale (VDS) is also called the Verbal Rating Scale (VRS) or the 
Graphic Rating Scale (GRS). These verbal rating tools are common and practical 
methods for assessing pain severity.  Verbal Rating Scales include a series of word 
descriptions of pain intensity in ascending order. The pain intensity scores are based 
to the score of the McGill pain Questionnaire (MPQ) being the most frequently used 
form (Melzack 1975). VDS is a 6-grade scale ranging from 0 = none, 1 = mild, 2 = 
uncomfortable, 3 = distressing, 4 = horrible to 5 = excruciating pain. The Verbal 
Rating Scale (VRS) pain measurement tool is a nondimensional and nonlinear a 
five-point verbal categorical rating scale. Pain is assessed by asking the patient to 
select the descriptor (0 = no pain, 1 = slight pain, 2 = moderate pain, 3 = severe 
pain, 4 = unbearable pain) that best describes the intensity of the pain.  A variation 
of the verbal rating scale includes a scale which has from 4 to 7 points, where the 
patient chooses the word that describes the pain “right now”. 
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The VRS is useful if the patient has a visual or motor impairment (Melzack 
1975), whilst the VDS is a valid and reliable method for young people (Jensen et 
al. 1986) and evidence supports its use for chronic pain measurement in the el-
derly (Melzack 1975; Gagliese and Katz 2003).  The VDS is reliable and has a high 
internal consistency as analyzed by Cronbach α (0.85-0.86), however test-retest 
reliability (r = 0.52-0.83) decreases in patients with cognitive impairment. The 
reliability of the VRS, on the other hand, has been validated in acute perioperative 
and postoperative pain, pain clinic, long-term care and community dwelling. VDS 
scales have also a strong positive correlation with other pain scales in many studies 
(Herr and Mobily 1993; Chibnall and Tait 2001; Herr and Garand 2001; Gagliese 
and Katz 2003; Gagliese et al. 2005). Verbal ratings scales (VRSs) provide a more 
sensitive tool for separating intensity and unpleasantness than nondescriptive sca-
les (Duncan et al. 1989). In particular, the VRS is considered the most effective 
scale in elderly patients with cognitive impairment possibly due to retention of 
long-term verbal associations (Weiner et al. 1998; Weiner et al. 1999; Morrison 
and Siu 2000; Titler et al. 2003; Rakel and Herr 2004). A smaller number of the 
description words utilized for five point ranging, may be less demanding for older 
patients with cognitive impairment.
VRS scales have a limited number of possible responses, and the scales are 
noncontinuous. Therefore, the use of nonparametric statistical analysis is needed 
and it makes the VRS weaker than the VAS in research approaches (Ohnhaus 
and Adler 1975). The choice of words is important; the pain intensity scale of the 
MPQ appears to be the most widely used English language version (Taylor and 
Herr 2003). Moreover, the translation into other languages has been performed, 
as seen for Finnish (Ketovuori et al. 1984).  The assessment of pain intensity by 
using verbal rating scales always demands language skills and patients need to 
communicate verbally.
5.3.3.2. Numerical Rating Scale
The Numeral Rating Scale (NRS) is a common and practical method for assess-
ing pain severity. It is the most widely used pain rating scale in clinical practice 
(Weiner et al. 1998; Weiner et al. 1999; Morrison and Siu 2000; Herr et al. 2004; 
Gagliese et al. 2005). The NRS is an 11-point verbal pain scale, where patients are 
requested to quantify the intensity of their pain on a scale from zero to 10 (from 
0 = no pain to 10 = worst pain imaginable). The variety of NRS scale ranges and 
anchors, including 0-5, 0-10, 0-20, and 0-100 scales, with 0 is no pain and 5 (10, 
20, 100) is the most intensive pain. The NRS scale can also be used visually with 
both words and numbers along a vertical or horizontal line. Patients are asked to 
express a number that relates best to their pain intensity. There is evidence, which 
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supports the validity and reliability of the NRS in younger (Jensen et al. 1986; 
Breivik et al. 2008) and older patients (Gagliese and Katz 2003).  
The numerical rating scale is widely used among patients in acute postopera-
tive care, pain clinic, long-term care and community dwelling. The verbal version 
requires the ability of abstract thought and may be difficult for older patients. The 
reliability of the NRS is acceptable and it has a high internal consistency, with a 
Cronbach α range of 0.86 to 0.88 (Hadjistavropoulos et al. 2007). As for the VRS, 
the test-retest reliability of the numerical rating scale (r = 0.57-0.83) decreases 
in patients with cognitive impairment (Hadjistavropoulos et al. 2007). A smaller 
number of choices (0-5) may be useful and not too demanding for older patients. 
This 5-point NRS scale has been validated as already described for the VRS and 
the VAS (Jensen and Karoly 1992). It is advantageous that not only is the NRS 
straightforward and fast to use, but the pain intensity of patients can also be asses-
sed without linear or visual representation, thus patients do not necessarily require 
visual skills. Nontheless, patients with cognitive impairment may have difficulty 
visualizing their pain in numerical terms and the numerical rating scale is not a 
suitable pain measurement tool for patients who are confused and disorientated 
(Hartrick et al. 2003).
5.3.3.3. Visual Analogue Scales (Figure 2, Table 2)
The Visual Analogue Scale (VAS) is a 10 cm line with endpoints labeled “no pain” 
and “worst possible pain”, where patients indicate the point on the line that best 
represents their current level of pain. The VAS maybe the most common pain 
measurement tool and it has become a standard tool in pain research and clinical 
practice (Scott and Huskisson 1976; Jensen et al. 1986). The VAS is reliable and 
well-validated and documented (Carlsson 1983; Chapman et al. 1985; Dalton and 
McNaull 1998). The internal consistency of the VAS is analyzed by Cronbach α 
0.87-0.88  and the reliability of the test-retest is acceptable (r = 0.75-0.83) (Had-
jistavropoulos et al. 2007). The VAS has a strong positive correlation with other 
pain intensity assessment tools (Herr and Garand 2001; Gagliese and Katz 2003; 
Ardery et al. 2003b; Taylor and Herr 2003; Breivik et al. 2008). However, many 
studies that have examined the reliability and validity of the VAS have either in-
cluded in a limited number of patients or excluded the elderly (Gagliese and Katz 
2003; Taylor and Herr 2003; Gagliese et al. 2005). Additionally, researchers have 
noticed that increased age was associated with a greater frequency of unreliable 
responses to the VAS (Benesh et al. 1997; Bergh et al. 2003). 
26
The VAS is validated to measure both chronic and experimental pain (Price et 
al. 1983). Many studies have shown the linearity of the VAS scale over a large range 
of acute pain intensity (Myles et al. 1999; Myles and Urquhart 2005). Therefore, 
studies support that the changes in the VAS score express a relative change in the 
magnitude of pain intensity. The VAS is simple and easy to use among many different 
languages. The VAS has been compared to VRS (4-point) and NRS-11 in acute pain 
(Breivik et al. 2000) and it was found to be more sensitive than VRS (4-point), while 
the VAS and the NRS (11-point) were approximately equal (DeLoach et al. 1998). 
Despite the fact that the VAS is a validated pain measurement tool, its ad-
ministration requires health professional or nursing resources that may decrease 
compliance for its use. The VAS may be difficult to use immediately after general 
anaesthesia (Aubrun et al. 2003), and is a unidimensional assessment tool of pain 
intensity. It cannot represent all factors of pain perception widely enough. There 
are many circumstances in clinical practice, where the VAS has a high failure rate, 
such as in situations when patients visual, cognitive, or motor skills are impaired, 
when patients are moderately sedated or confused, and those in very severe pain 
with agitation (Benesh et al. 1997; Krulewitch et al. 2000; Bergh et al. 2001; Ga-
gliese and Katz 2003; Closs et al. 2004; Herr et al. 2004; Gagliese et al. 2005; 
Pautex et al. 2005). 
5.3.3.4. A 50 cm Red Wedge Scale (Figure 2, Table 2)
A 50 cm Red Wedge Scale (RWS) is a modified enlargement of the ordinary visual 
analogue scale. It is a 50 cm red coloured horizontal wedge (15 cm high at its end) 
which was developed initially for the assessment of pain immediately after surgery 
in patients recovering from general anesthesia (Tigerstedt and Tammisto 1988; 
Tarkkila and Saarnivaara 1999; Silvasti and Pitkänen 2001; Leino et al. 2011). A 50 
cm Red Wedge Scale is simple and straightforward to use like the visual analogue 
scale (VAS). The advantage of the RWS is the large size. This scale is not widely 
used and it is not a validated ratio measure of chronic pain or clinical acute pain. 
This pain assessment tool is often used in research (Silvasti and Pitkänen 2001) 
and in clinical practice in Finland, but it is not well-known in other countries.
5.3.3.5. Facial Pain Scales (Figure 2, Table 2)
The Facial Pain Scale was first developed by Wong and Baker and it is recommended 
for patients aged over three years (Wong and Baker 1988). The scale was developed 
by asking children to draw their impression of facial expressions from no pain to 
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worst pain. A smiling face was most often drawn as the “no pain” anchor and the 
face with tears described the worst pain; although a neutral rather than happy 
no-pain anchor was employed by Bieri et al. (1990) associated with no tears at the 
upper anchor and less emotive expressions. A row of the six or seven different face 
pictures indicate the intensity of pain in this model, to which the numerical rating 
of pain intensity may be adapted under the different faces from 0-5 or to 0-10. The 
patient is asked to choose the face that best describes how they feel in this widely 
used pain measurement tool for children. The Facial Pain Scale approach is also 
practical for older adults in the clinical assessment of pain intensity (Bieri et al. 
1990; Herr et al. 1998; Chibnall and Tait 2001; Taylor and Herr 2003; Kaasalainen 
and Crook 2003; Herr et al. 2004; Li et al. 2007; Li et al. 2009), in fact Bieri’s 
modified version is also validated in adults (Bieri et al. 1990; Hicks et al. 2001).
The Facial Pain Scales are validated and reliable in children (Wong and Baker 
1988; Bieri et al. 1990). The reliability of this pain scale has been measured by in-
ternal consistency Cronbach α (0.88-0.89) and by test-retest reliability (r = 0.44-
0.94) (Kim and Buschmann 2006; Ware et al. 2006). The FPS is widely used and 
well-tested for both acute postoperative pain and chronic pain for both hospital and 
community dwelling patients, but its correlation with other pain intensity scales is 
quite weak. The FPS does not demand language and it is simple to use in clinical 
practice at all levels of heath care organization. 
The use of facial pain scale figures may increase the possibility of confounding 
the results with emotional feelings such as depression that can change the degree 
of the pain intensity reported. Therefore, the differences of the faces may not be 
linear in terms of pain intensity and the facial scale may possess different degrees 
of sensitivity, although it is reported to be valid and reliable to measure pain (Kim 
and Buschmann 2006).
5.3.3.6. McGill Pain Questionnaire (Table 2)
The McGill Pain Questionnaire (MPQ) was developed in 1975 by Melzack for as-
sessment of chronic pain. The MPQ is made up of 20 categories of adjectives that 
describe the qualities of pain. Patients choose those words or adjectives that the 
best describe their feelings and intesity of pain at that moment. The rank values 
of chosen words are summed to obtain total score. The MPQ includes three major 
measures; (1) Pain Rating Index (PRI), that is based on two types of numerical 
values that can be assigned to each word descriptor, (2) the number of the words 
chosen; and (3) the present pain intensity based on a 1-5 intensity scale, that is a 
modified single dimension five-point verbal descriptive rating scale (Melzack 1975). 
The MPQ is a multidimensional pain measurement tool. Evaluative, affective, and 
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sensory are the three dimension of the PRI’s. The MPQ and the subclasses of the 
PRI have been found to be reliable and valid pain assessment tools. (Melzack 1987). 
The reliability of the MPQ has been found to vary from inadequate to adequate, 
whilst internal consistency has been measured by Cronbach α 0.41-0.98, and high 
test-retest reliability has been shown for total, sensory, affective, and average pain 
scores (Gagliese and Melzack 1997; Luggen 1998; Zalon 1999; Gloth et al. 2001; 
Grafton et al. 2005).  The short-form MPQ (SF-MPQ) was modified by Melzack in 
1987 (Melzack 1987) and includes sensory (sharp, shooting, etc.) and four affective 
(sickening, fearful, etc.) verbal descriptors. The patient rates the intensity of each 
descriptor on a scale from 0 to 3 (3 = severe). Three pain scores are calculated: the 
sensory, the affective and total pain index. The SF-MPQ includes visual analogue 
and verbal rating scales of pain intensity (Grafton et al. 2005; Melzack 2005). The 
MPQ has been translated into many languages; the Finnish version was translated 
from English (Ketovuori et al. 1984). The original MPQ is impractical in the clinical 
setting because the questionnaire is long and a nurse must pose the questions with 
the assessment of pain intensity taking at least fifteen minutes. Although the MPQ 
is a validated multilanguage tool for measuring chronic pain (Gagliese and Melzack 
1997), it is an unsuitable pain measurement scale for routine clinical use to measure 
pain levels in the postoperative period. A newer preliminary version of SF-MPQ-2 
has been developed to be a comprehensive measure of pain quality in both clinical 
research and clinical practice.  The SF-MPQ-2 includes a single measure of the major 
sensory and affective symptoms of both neuropathic and non-neuropathic pain. It 
can be applied to epidemiology, natural history, pathophysiologic mechanisms and 
treatment response studies (Dworkin et al. 2009).
5.3.3.7. Behavioral Pain Assessment Tools and Scales
There are many circumstances when self-reporting of acute pain is not possible and 
the intensity of pain may be assessed using behavioral pain scores. In typical situa-
tions, patients are under the influence of residual sedatives or general anaesthetic 
agents, cannot respond verbally, and may have severe cognitive impairment or be 
intubated and sedated. Several attempts have been made to develop observational, 
clinically relevant tools for patients unable to self-report. Clinically relevant pain 
measurement tools may be categorized into those that are brief (compromising of 
10 items or less) and those that are extended (compromising of more than 10 items) 
(Hadjistavropoulos et al. 2007). The most common method for determining the 
behavioral component of a patient’s pain is by direct observation. The behavioral 
pain measurement scales of 10 items or less are the Discomfort Scale (DS-DAT) 
(Hurley et al. 1992), Checklist of Nonverbal Pain Indicators (CPNI) (Feldt 2000), 
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Pain Assessment in Advanced Dementia (PAINAD) (Warden et al. 2003), Pain As-
sessment in the Communicatively Impaired (PACI) (Kaasalainen and Crook 2003), 
Abbey Scale (Abbey et al. 2004), Non-communicating Patient’s Pain Assessment 
Instrument (NOP-PAIN) (Snow et al. 2004), the Doloplus-2 (Wary and Doloplus 
1999), and the Pain Assessment Tool in Confused Older Adults (PAT-COA) (Decker 
and Perry 2003).  Despite the numerous behavioral pain scales, many studies have 
shown that the majority of these measures have unsatisfactory or unreported in-
ternal consistency, introducing uncertainty about whether items measure the same 
construct (Feldt 2000; Decker and Perry 2003; Warden et al. 2003). 
Numerous behavioral pain measures of more than 10 items have been developed 
to assess pain among patients with dementia. These tools are Amy’s Guide (Galloway 
and Turner 1999), The Pain Assessment in demented Elderly Scale (PADE) (Simons 
and Malabar 1995), and the Pain Assessment Checklist for the Seniors with Limited 
Ability to Communicate (PACSLAC) (Fuchs-Lacelle and Hadjistavropoulos 2004).
The relationship between behavioral tools and the pain intensity rating has not 
been declared. However, behavioral scales may be the only possible assessment 
tools for severely demented patients, where the behavioral pain scales may not 
be suitable for general postoperative pain assessment (Wary and Doloplus 1999; 
Morrison and Siu 2000; Fuchs-Lacelle and Hadjistavropoulos 2004).
5.3.3.8. Problems in assessing pain in dementia
Dementia causes serious and unique barriers to pain assessment. It can be gener-
ally characterized by memory loss, personality changes, and loss of many functions 
such as abstract thinking, language skills and judgement. The impairment level is 
often categorized by measurement of the Mini Mental State Examination (MMSE) 
score (Folstein et al. 1975). The impact of dementia on pain processing varies in 
direction and quality, depending on the type of pain, neuropathology and stage of 
dementia. Self-reporting is considered to be the standard of pain assessment and 
these scales require the capacity to understand the task and to communicate about 
pain experienced. Ageing has been associated with difficulties in grasping abstract 
concepts that creates difficulty in using scales requiring cognitive skills (Gagliese and 
Melzack 1997). Accordingly, recent studies describe the insufficient reliability and 
validity of self-report scales in patients with dementia (Fisher et al. 2002; Pautex 
et al. 2006), suggesting that behavioral and observational assessment scales are 
required (AGS Panel on Persistent Pain in Older Persons 2002). However, typi-
cal pain behaviors may be absent or difficult to interpret among non-verbal older 
patients with severe dementia (Fuchs-Lacelle et al. 2008).
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5.4. physiologiCal Changes in the elderly
Physiological changes in the elderly may affect in the management of pain. There 
are age-related differences in the perception of, and response to, pain (Gibson and 
Helme 2001). The response to mild pain is often reduced in many older patients. 
On the other hand, older people may be more sensitive to severe pain. The reasons 
for these age-related changes are still unclear (Gibson and Helme 2001). 
5.4.1. physiologiCal Changes in CardioVasCular funCtion  
in elderly people
Cardiovascular disease affects approximately 50 to 65% of elderly patients; physi-
ological changes include a decrease in cardiac index of 1% per year after the age 
of 30 years (Lund-Johansen 1988; Tumer et al. 1992). Furthermore, hypertension 
can reduce cardiac function and the subsequent lower cardiac output induces a 
decrease in hepatic blood flow. This in turn impacts on the clearance of opiods 
that have relatively high extraction ratios across the liver (Upton and Huang 1993; 
Aubrun et al. 2002; Macintyre 2005). Furthermore, reduced cardiac output can 
lead to higher peak arterial opioid concentrations after intravenous administration, 
as a function of dilution, cardiac output, and the kinetics of the first pass of the 
drug through the lungs. Therefore, the strategy for administration of intravenous 
opioids therefore is to reduce the initial dose and to use slower injection rate in 
elderly (Upton 1996; Weiss et al. 1996).
5.4.2. physiologiCal Changes of the Central and peripheral nerVous 
system in elderly patients
The elderly have a reduction in cerebral blood flow, and an increased responsiveness 
to CNS-active medications (Tumer et al. 1992). Sub-cortical and cortical atrophy 
decreases receptor sites, receptor affinity and the synthesis of the neurotransmit-
ters acetylcholine, dopamine, GABA and noradrenaline. Neuronal loss is greatest in 
the neocortex and hippocampus (mainly in region of locus ceruleus and substantia 
nigra) and may affect pain. G-proteins, a secondary mediator of the action of many 
receptors including opioid receptors, have decreased coupling. There is reduced 
catalytic activity of adenylate cyclase which is a secondary mediator of pain. Many 
of these changes provide reason for drug-induced delirium and reduced drug toler-
ance in the elderly (Tumer et al. 1992; Davis and Srivastava 2003).
Nerve conduction is slowed in the aged. There is an age-related decrease in the 
capacity or speed of processing of nociceptive stimuli. Furthermore, C and Aδ fiber 
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function decreases with age. A corresponding degeneration of electrical conduc-
tion occurs along motor pathways. Peripheral motor nerve conduction decreases 
by about 0.15 m/s/year (Harkins et al. 1994). There are structural, biochemical, 
and functional changes in the peripheral nervous system with age, together with 
increased neuronal damage and deterioration. There is a reduction in the con-
tent and turnover of neurotransmitter systems, that is known to be involved with 
nociception (Clark et al. 2004). A slowing in peripheral nerve conduction velocity 
and similar changes in the central nervous system may be the cause of the change 
in pain sensitivity. Many studies have shown that the age-related pain threshold 
changes, although some results of the studies were in contradiction with each other. 
Furthermore, many studies have been methodologically weak (Harkins et al. 1994; 
Gibson and Helme 2001; Gagliese and Katz 2003). Overall, most studies have docu-
mented that the elderly demonstrate an increase in the pain perception threshold.
5.5. CliniCal pharmaCology in the elderly
Age-related physiological changes affect different organ systems. Therefore, im-
portant pharmacodynamic and pharmacokinetic changes occur with advancing 
age. Moreover, the individual variability in the physiological responses increases 
with age. Ageing is not a single matter but a collective term representing the sum 
of cumulative local effects at molecular, cellular and tissue level. The most logical 
change is the time-related loss of organs functional units like as nephrons in kid-
ney, alveolis in lungs and neurones in brains. This reduction of functional reserve 
is associated with a decrease in viability and an increase in vulnerability (Mangoni 
and Jackson 2004).
5.5.1. pharmaCoKinetiC Changes in the elderly
5.5.1.1. Absorption
The oral absorption of drugs remains stable in elderly patients with an intact gastric 
mucosa, despite increased gastric pH and decreased gastrointestinal blood flow. 
However, absorption may be altered by nutritional deficiencies, partial gastrectomy, 
and drug interactions with laxatives, antacids, and agents that decrease gastric emp-
tying. In general, the rate and extent of drug absorption from the gastrointestinal 
tract remains unchanged (Cusack et al. 1980). Using paracetamol as a marker, it has 
been shown that the rate of gastric emptying and absorption of orally administered 
drugs does not change substantially with age (Gainsborough et al. 1993). Aging is 
associated with a reduction in first-pass metabolism because of the reduction in liver 
blood flow. Decreased hepatic clearance and its causes correspondingly increases 
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bioavailability leading to higher blood concentrations of some orally administered 
drugs (Mangoni and Jackson 2004). 
5.5.1.2. Distribution
The volume of distribution (VD) is not an actual physiological measurement but 
it is pharmacokinetic measurement defined as the amount of drug in the body 
divided by the concentration of drug in the blood or plasma per kilogram of body 
weight. Increasing age is associated with increased body fat and reduction in the 
total body water. Drugs that distribute into muscle or into body water will achieve 
a high initial plasma concentration after administration as a decrease in their VD. 
Water-soluble drugs are distributed less effectively in elderly patients with dec-
reased muscle mass and body water. The smaller volume of distribution causes 
higher serum levels of water soluble drugs in elderly patients. The increase in fatty 
tissue in the elderly increases the V
D
 of lipophilic drugs because fat acts as a depot 
of these agents which include diazepam and haloperidol (Bressler and Bahl 2003).
The binding of drugs to plasma proteins usually decreases with aging. Nonthe-
less, no changes are observed in the binding of α1-acid glycoprotein to basic drugs. 
Most drugs are acidic and thus are instead bound by serum albumin. Total serum 
albumin and its drug binding capacity is decreased by about 12% in elderly patients. 
Given that free drug concentrations determine the pharmacological effect, because 
bound drug cannot bind to target tissues, the total plasma levels in the elderly are 
thus likely to be decreased. This effect may also accentuated by the observation that 
many diseases in the elderly can depress albumin levels; including chronic diseases 
that require drug therapy, such as heart failure, renal disease, rheumatoid arthritis, 
hepatic cirrhosis, and some malignancies. Decreased protein binding causes to the 
need to adjust doses for elderly patients. Renal disease is documented to decreased 
plasma albumin and it may lead to acidosis, both of which will decrease drug bin-
ding (Bressler and Bahl 2003).
5.5.1.3. Drug elimination
Clearance and half-life
Two pharmacological concepts, clearance and half-life, are important to understand 
therapeutic and adverse drug reactions in the elderly. The effects of the drugs relate 
to the level of drug concentration in the blood, thus the processes that eliminate 
drugs from the blood become significant considerations (Bressler and Bahl 2003). 
Clearance is the measure of fractional loss of the drug per unit time, therefore the 
amount of blood volume completely cleared of drug per unit time. It represents the 
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efficiency of drug extraction from blood. Clearance does not direcly indicate how 
much drug is being removed, on the contrary, it suggests the volume of plasma that 
would need to be freed of drug to account for the elimination of the drug (Bressler 
and Bahl 2003).
The half-life of a drug is the time which it takes for the drug concentration in 
plasma to decrease by 50% after drug distribution. The elimination half-life of drugs 
increases with age. This may be caused by decreases in drug clearance. 
Metabolism and changes in hepatic function
Aging is associated with a reduction in hepatic function. A 1% decline in cardiac 
output per year after the age of 30 induces a 0.5 to 1% reduction in hepatic blood 
flow with a decrease in liver clearance (Aubrun 2005). The activity of hepatic mi-
crosomal enzymes declines slowly with age, while the distribution volume of lipid-
soluble drugs increases, because of the proportion of body fat increases with ageing.
Elimination and changes in renal function
The main reason for changes in drug action in the elderly, is that drug elimination 
is less efficient in old people. Therefore, drugs produce greater and more prolonged 
effects at the extremes of life. Renal function decreases with age (Hansen et al. 
1970; Papper 1973). Total renal blood flow decreases 10% per decade in adults 
and the glomerular filtration rate (GRF) reduces 1 to 1.5% per year after the second 
decade. Also the aging influences tubular secretion, tubular reabsorption, and renal 
metabolism. Creatinine clearance gives the most reliable measurement of GFR. 
The measurement of serum creatinine remains often within normal range despite 
of impaired GRF.  The marked reduction of the proportion of the skeletal muscle 
to total body mass causes a small creatinine load. Creatinine values are based on 
catabolism of muscles, and are not a sensitive measure of renal function in the 
elderly. A 50 to 70% decrease in the GRF induces only a moderate increase creati-
nine concentration. The drugs that are eliminated substantially by renal excretion 
should be given in reduced doses and less frequently to older patients in order to 
avoid accumulation and untoward pharmacologic effects.
5.5.2. pharmaCodynamiC Changes in the elderly
Significant pharmacodynamic changes occur in the elderly, which tend to indefi-
nitely increase drug sensitivity. The effect of age on drug sensitivities varies with 
the drug studied and the response measured, thus generalizations are difficult to 
make. Studies of drug sensitivity require measurement of concentrations of drug 
in plasma as differences in pharmacokinetics with increasing age may increase or 
decrease differences in response to the drug (Mangoni and Jackson 2004; Bowie and 
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Slattum 2007). Only a few studies of pharmacokinetic-pharmacodynamic relation-
ships for opioids have been reported, most of which have used a measure of effect 
other than clinical pain relief. The effects of fentanyl, alfentanil and remifentanil 
were investigated on the electroencephalogram (EEG) and it was concluded that 
the kinetics of these opioids were not influenced by age. However, the sensitivity of 
the brain to opioids was increased by 50 percent (Scott and Stanski 1987a ; Minto 
et al. 1997). Aging is also associated with increased sensitivity to the central nerv-
ous system effects of benzodiazepines, although the exact mechanisms for this  are 
unknown (Kruse 1990).
5.5.2.1. Sensitivity
The changes in altered responsiveness to drugs may occur at the level of receptor 
(biochemical, structural, translational), tissue or organ, and homeostasis. Aging 
is associated with lower receptor density or changed characteristics, such as the 
sensitivity to catecholamines. The number of receptors can also be altered rapidly 
in terms of up or down regulation by both physiological and pathological processes, 
as well as by drugs (Tumer et al. 1992).
5.6. pain management in the elderly
The main goal of pain management is pain reduction associated with improved 
function, reflected in the activities of daily living, sleep, and well-being after surgi-
cal operations or chronic painful diseases. Management strategies for acute and 
chronic pain in the elderly comprise combinations of treatments. These may be 
relatively common using opioid and non-opioid analgesics, or more complicated 
approaches using combinations of regional or local blocks with opioids, non-opioid 
analgesics, or both. Pain treatment strategies do not differ between middle-aged and 
elderly patients in normal clinical practice, although it is well-known that aging is 
associated with decreased organ function, varied responses to drugs, and increased 
incidence of multi-system disease.
5.6.1. opioids in the pain management in the elderly
Opioids are a mainstay for treating acute moderate and severe postoperative pain in 
the elderly. Many studies have shown that the elderly require less opioid for man-
agement of acute pain than younger patients (Macintyre and Jarvis 1996; Coulbault 
et al. 2006). Safe and effective opioid analgesia requires age-related dosage sched-
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ules, careful titration of effects, intensive assessment of pain, the use of a suitable 
drug and route, in addition to awareness of problems with metabolites of opioids. 
Age appears to be a better determinant of the dose of an opioid than the patients 
weight (Gagliese et al. 2000; Aubrun et al. 2003; Aubrun and French Society of 
Anesthesia and Resuscitation 2009). On the other hand, the decrease in opioid 
requirement is not associated with reports of increased pain. The use of opioids is 
becoming more acceptable for the management of chronic pain that impairs daily 
function and quality of life in elderly patients (AGS Panel on Persistent Pain in 
Older Persons 2002; Reid et al. 2010). 
5.7. pain management during CardiaC anesthesia
5.7.1. fentanyl in CardiaC surgery anaesthesia
Fentanyl, (N-(1-phenethyl-4-piperidyl) propionanilide), is a µ-receptor agonist and 
a synthetic opioid with high potency and lipophilicity. It is structurally related to 
meperidine. The widespread use of fentanyl began between the years 1975 and 
1981. It is a potent intraoperative analgesic agent with relatively few adverse ef-
fects, haemodynamics remains stable when fentanyl is used to induce and maintain 
anesthesia in critically ill patients. An elimination half-life of fentanyl is 3.5 hours 
and the time to peak effect is about 4 minutes. Fentanyl is metabolized in the liver 
to yield metabolites (Hudson et al. 2002), the pharmacological activity of which 
is unknown; however they appear to be clinically insignificant. Less than 10% of 
fentanyl is removed unchanged by the kidney (McClain and Hug 1980; Shafer et 
al. 1990).
High-dose (50-150 µg kg-1) fentanyl was used widely for cardiac anaesthesia in 
the late 1970s because of its superior haemodynamic profile, however this approach 
was abandoned due to dose dependent bradycardia, chest wall rigidity and the need 
for prolonged mechanical ventilation. Nontheless, intermediate-dose (10-15 µg kg-
1) fentanyl remains the mainstay of balanced general anaesthesia in many centers 
(Ahonen et al. 2000; Hudson et al. 2003; Silbert et al. 2006). After intravenous 
administration, fentanyl distributes rapidly from plasma to vascular tissue, muscle 
and fat (McClain and Hug 1980). Removal of fentanyl from muscle and fat is slower 
than uptake and after continuous long-term administration fentanyl accumulates 
in the body (Stanski et al. 1978). 
Fentanyl has been administered via intramuscular, intravenous (bolus, injection, 
infusion, patient-controlled analgesia), neuraxial and inhalational routes. Recent-
ly, new administration routes have also been developed, including a trans-dermal 
patch for use in chronic pain (Clark et al. 2004). Opioid related side effects such 
as respiratory depression, sedation and itching are to be expected, thus fentanyl 
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should be used only when ventilation is controlled or it can be monitored. Fentanyl 
is still widely used as an anesthetic agent in adults undergoing cardiac surgery for 
whom fast postoperative recovery and earlier tracheal extubation have become an 
important goal in their anaesthetic management. Additionally, fentanyl is used as 
a postoperative analgesic, typically administered either intermittently (0.5-2 µg/
kg) or as an infusion (0.5-2 µg/kg/h). Fentanyl has an excellent haemodynamic 
stability and limited allergic potential (Howie et al. 2001; Myles et al. 2002; Payen 
et al. 2007).
5.8. pain management in the intensiVe Care unit after 
CardiaC surgery patients
Pain intensity after cardiac surgery is moderate or severe and often under-treated. 
Opioids, paracetamol, and more recently anticonvulsants are used as an analgesic 
regimen after cardiac surgery in the intensive care (Diby et al. 2008; Layzell 2008; 
Menda et al. 2010). The incidence of chronic pain after cardiac surgery varies from 
21 to 55% (Macintyre and Russell 2003; Lahtinen et al. 2006; Macintyre et al. 
2006). Risk factors for chronic pain are younger age (< 60 years), longer duration 
of surgery (> 2 hours), depression, cultural background, female gender and low 
education (Kehlet et al. 2006; Sommer et al. 2008; Tan et al. 2008). 
5.8.1. oXyCodone in postoperatiVe pain management after  
CardiaC surgery
Oxycodone has been widely used for the relief of moderate and severe acute post-
operative pain and cancer pain in Finland since the 1960s (Kalso 2005b). It can be 
administered via a variety of routes including oral or rectal, intramuscular, intrave-
nous, or subcutaneous injection. Oxycodone (14-hydroxy-7,8-dihydrocodeinone) is 
a semisynthetic opioid analgesic and an agonist of µ-opioid receptors. It also binds 
to κ-opioid and δ-opioid receptors with a lower affinity than to µ-receptors. The 
volume of distribution of oxycodone is about 2-3 L/kg and its elimination half-life 
is about 2.3-2.6 hours after i.v. administration. The maximum plasma concentra-
tion of oxycodone is achieved within 25 min. after i.v. administration (Pöyhiä et 
al.1991). Intravenous oxycodone was associated with a rapid pain relief in between 
five to eight minutes. Alternatively, oxycodone is well absorbed after orally dosing, 
with more bioavailability than morphine when it is given orally (Pöyhiä et al. 1992). 
Oxycodone has been found to be more potent than morphine for visceral pain relief 
but not for sedation after laparoscopic hysterectomy (Kalso et al. 1991; Lenz et al. 
2009). Oxycodone is available as single agent, in controlled release (CR) and im-
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mediate release (IR) formulations. The elimination half life is about 3 hours after 
(IR) oxycodone and about 8 hours after (CR) oxycodone, however the maximum 
plasma concentrations of oxycodone are achieved after 1.3 h after IR and 2.6 h after 
CR oxycodone (Mandema JW et al. 1990).
Oxycodone is mainly metabolized in the liver through the cytochrome P450 
enzyme system to noroxycodone via a major pathway (CYP3A) and to oxymorpho-
ne via a minor pathway (CYP2D6). Noroxycodone is a weak opioid agonist and it 
has a little antinociceptive activity. This active metabolite increases the potential 
for interractions with other drugs metabolized by the CYP3A4 pathway. Oxymor-
phone metabolite forms only small amounts after oxycodone administration. It has 
greater µ-receptor binding affinity than oxycodone. Noroxymorphone is a second 
oxidative metabolite producted by O-demethylation of noroxycodone. However, 
the analgesic effect of noroxycodone is not yet clearly known (Lalovic et al. 2004). 
Oxycodone metabolism can differ in population according to age, sex, and ethi-
nicity. The plasma concentrations of oxycodone might be higher in elderly and in 
female compared to younger and male subjects (Kaiko RF et al 1996). The ethinicity 
and genetic background have impact to the metabolism of oxycodone to oxymorpho-
ne. The minor part (1-7%) of Caucasians are ultra-rapid CYP2D6 metabolizer and 
the small part (5-10%) of people are poor metabolizers due to decreased CYP2D6 
activity. Therefore, the ultra-rapid CYP2D6 metabolizers may reduce analgesic res-
ponse. In contrast, the poor metabolizers may increase analgesic and adverse effects 
of oxycodone (Kalso E 2005b).
Oxycodone and its metabolites are excreted and eliminated via the kidney. About 
8 to 14% of  oxycodone doses are excreted as free oxycodone, about 50% as conju-
gated oxycodone, 0% as a free oxymorphone, and 14% as conjugated oxymorpho-
ne, while free and conjugated noroxycodone have been demonstrated. Therefore, 
oxycodone elimination is decreased with renal insufficiency due to a large volume 
of distribution and reduced clearance (Pöyhiä et al. 1993;  Kirvelä M et al. 1996). 
Parenteral oxycodone is used as a primary opioid for early postoperative pain after 
cardiac surgery in Finland (Lahtinen et al. 2002; Lahtinen et al. 2004). Typically 
the administration of oral oxycodone is started on the first postoperative day and 
patients usually routinely receive additional analgesia with paracetamol after car-
diac surgery.
5.8.2. side effeCts of opioids in the elderly
The potential for side effects is greater in the elderly because of changed distribution 
and excretion of drugs. Also, impairment of renal and hepatic function is common in 
the elderly. Renal dysfunction increases the half life of active drug and metabolites, 
therefore the risk of opioid side effects increases in the elderly (Bressler and Bahl 
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2003; Bowie and Slattum 2007). The most commonly reported adverse effects in 
the elderly are constipation, nausea, dizziness, somnolence and respiratory depres-
sion (Roth et al. 2000). The risk of respiratory depression and over sedation are 
known to be greater in the elderly than in younger adults. The best and the earliest 
clinical symptom of respiratory depression appears to be sedation (Vila et al. 2005). 
Sedation should be monitored in elderly patients given opioids by using a sedation 
score, such as the doses of opioids should be reduced in elderly. The level of sedation 
must be followed intensively during pain management (Bressler and Bahl 2003). 
Postoperative nausea, vomiting and constipation are common side effects that are 
more likely for female patients, non-smokers, the aged, those using opioids, and 
those suffering anxiety (Roth et al. 2000). 
5.9. postoperatiVe Confusion, CognitiVe dysfunCtion 
and delirium after CardiaC surgery
Patients who undergo cardiac surgery have a higher risk of developing postoperative 
confusion and delirium. Known risk factors for confusion and delirium are advanced 
age, preexisting cognitive impairment, medications, administration of intraoperative 
and postoperative anesthetic and analgesic including opioids. Delirium or acute 
postoperative confusion is a temporary mental disorder, which appears frequently 
among hospitalized elderly patients. The incidence and prevalence of delirium vary 
widely among different study populations. Generally, delirium has been related to 
the long term cognitive and functional recovery, prolonged ICU and hospital stay 
and nursing home placement (Inouye et al. 1999; Koster et al. 2008). 
5.10. paraCetamol
Paracetamol is widely used as an analgesic agent for postoperative pain or chronic 
pain in combination with opioids. It is well established as an effective and well 
tolerated drug for the management of mild and moderate pain. Paracetamol is 
recommended as a first line analgesic for the treatment of pain and fever in adults 
and children and is often used as a routine background analgesic in combination 
with opioids. Paracetamol has oral, rectal, and intravenous formulations. The in-
travenous route is especially advantageous after surgery, when it is not possible to 
use oral or rectal routes (Holmér Pettersson et al. 2006). 
Despite many clinical studies and the widespread clinical use of paracetamol, the 
mechanism of paracetamol’s analgesic action is not fully understood. Paracetamol 
has an influence on both the central and peripheral components of the pain pathway 
(Bonnefont et al. 2003). It has been shown to contribute to the direct inhibition of 
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the N-methyl-D-aspartate receptor, which stimulates the substance P-dependent 
synthesis of nitric oxide; it also inhibits prostaglandin synthesis. Recent findings 
suggest that the mechanism of paracetamol analgesic action is associated with the 
serotoninergic system (Pickering et al. 2006).  Paracetamol is commonly adminis-
tered to elderly patients, and the clinical pharmacological properties of paracetamol 
are well-known in the elderly. Liukas et al. have studied the pharmacokinetics of 
intravenous paracetamol in elderly patients, finding that a higher age and being 
female were associated with a higher exposure of paracetamol (Liukas et al. 2011).
5.10.1. paraCetamol in postoperatiVe pain management after CardiaC 
surgery
Intravenous paracetamol is used for early postoperative pain management when 
patients are intubated and not able to take an oral analgesic. Oral paracetamol 
is used as soon as possible after extubation. The first initial intravenous prodrug 
formulation of paracetamol (propacetamol) was used for adults as an alternative to 
NSAIDs in the preoperative and postoperative period. Propacetamol reduced mor-
phine consumption by 22 to 46% in patients undergoing major orthopaedic surgery 
(Remy et al. 2005). Alternatively, a new intravenous paracetamol, Perfalgan ®, is 
very well tolerated in many clinical studies (Grundmann et al. 2006; Kemppainen 
et al. 2006; Atef and Fawaz 2008). Intravenous paracetamol is considered to be 
a safe drug after cardiac surgery as emergency adverse reactions occur extremely 
rarely (Gregoire et al. 2007). Intravenous paracetamol is not associated with gas-
trointestinal lesion ulceration, renal dysfunction, or bleeding caused by platelet 
inhibition. Intravenous paracetamol in combination with tramadol provides effec-
tive pain control after cardiac surgery (Cattabriga et al. 2007). Holmér Pettersson 
et al. have studied plasma concentration following repeated rectal or intravenous 
administration of paracetamol after heart surgery. An initial intravenous dose of 
paracetamol has been found to be a valid method for reaching an early effective 
plasma concentration (Holmér Pettersson et al. 2006).
5.10.2. Combination of oXyCodone and paraCetamol in the postop-
eratiVe pain management
Pain is caused by multiple mechanisms of action. Consequently, the use of com-
bination analgesic therapy has an influence on several targets and processes in 
pain reduction. The combination of oxycodone and paracetamol, for example, may 
decrease dose-related side effects as lower doses of the component drugs are used 
in chronic non-malignant pain and acute postoperative pain (Lahtinen et al. 2002; 
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Remy et al. 2005; Barkin 2001). Opioids are a cornerstone of postoperative pain 
management after sternotomy despite the numerous unwanted side effects. Nau-
sea and vomiting, drowsiness, respiratory depression, constipation and bladder 
dysfunction are often observed during opioid analgesia.  Multimodal or balanced 
analgesia, that is the combination of non-opioid analgesic to opioid, have been 
proposed to decrease opioid consumption, as seen for morphine or oxycodone, and 
to improve postoperative pain management after surgery (Kehlet and Dahl 1993). 
NSAIDs have numerous disadvantages such as bleeding and renal complications. 
Regional neuraxial anaesthesia is controversial due to the anticoagulation triggered 
in cardiac surgical patients. Therefore, intravenous or oral paracetamol combined 
with oxycodone is routine regimen in our clinical practice. Paracetamol is consid-
ered to be quite safe, even though it is not so highly effective, but in comparison, 
adverse effects of opioids have not been shown to decrease upon dosage reduction 
in the postoperative period (Remy et al. 2005). A meta-analysis was published by 
Marret et al, where the benefits of combining NSAIDs and morphine to decrease 
opioid-related side effects such as PONV and sedation but not pruritus, urinary 
retention, or respiratory depression (Marret et al. 2005). However, the combination 
of oxycodone and paracetamol may decrease the dose-related side effects of opioids 
as lower doses of opioid are used in postoperative pain (Barkin 2001).
5.11. gabapentinoids
Gabapentin and the related compound, pregabalin, are efficacious drugs in the 
treatment of  different disorders including epilepsy, acute and chronic pain (Dal-
locchio et al. 2000; Dworkin et al. 2003; Frampton and Scott 2004; Rorarius et 
al. 2004; Tiippana et al. 2007), and anxiety (Rickels et al. 2005). Pregabalin has 
been shown to effectively decrease cancer-associated neuropathic pain, diabethic 
neuropathy, post-herpetic neuralgia, reflex sympathetic dystrophy and trigeminal 
neuralgia (Dallocchio et al. 2000; Eckhardt et al. 2000).
5.11.1. pregabalin -meChanism of aCtion, pharmaCoKinetiCs and side 
effeCts
Pregabalin is a specific ligand of the alpha-2-delta type 1 and 2 subunits of volt-
age-gated calcium channels, thus decreases depolarization-induced calcium influx 
at nerve terminals (Taylor et al. 1993). Pregabalin also decreases calsium inward 
currents, and reduces glutamate, norepinephrine and substance P content in the 
brain (Dooley et al. 2000). Pregabalin is structurally related to GAB
A
 (gamma-




 receptors and 
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is not an inhibitor of GAB
A
 uptake or degradation (Ben-Menachem 2004; Bialer 
et al. 2004; Bialer 2005).
Pregabalin is fast and extensively absorbed after oral dosing; a maximal plasma 
concentration is achieved 1 hour after single or multiple doses. The steady state of 
the drug is reached within 24-48 h after repeated administration (Ben-Menachem 
2004). Pregabalin can be started at an effective dose of 150 mg/day. Maximal plasma 
pregabalin concentrations (C max) and total exposures (AUC) are proportional to 
dose after either single or repeated dosing. The oral bioavailability of pregabalin is 
high at over 90% and is independent of the dose and the drug undergoes minimal 
metabolism (< 2%). Therefore, 98% of the drug is secreted as unchanged drug by 
renal excretion. The half-life of pregabalin is 5.8-6.3 hours and it is not bound to 
plasma proteins (Bialer et al. 2004). Furthermore, pregabalin should have a very 
low potential for drug-drug interactions because it is not subject to hepatic meta-
bolism and does not induce or inhibit liver enzymes such as the cytochrome P450 
system. While pregabalin is neither metabolized nor bound to plasma proteins, it 
is not expected to trigger drug-drug interactions via these mechanisms in clinical 
practice. The lack of remarkable drug interactions is a benefit as pregabalin can 
be safely used with other durgs. It should be suitable for elderly patients who may 
receive other medications (Ben-Menachem 2004).
Pregabalin is well tolerated and associated with dose-dependent adverse events. 
Dizziness and somnolence are the most frequently reported side effects. Also dry 
mouth, peripheral edema, blurred vision, weight gain and abnormal thinking have 
been reported pregabalin treated patients (Gajraj 2007).
5.11.2. pregabalin for aCute pain in adults
Gabapentinoids, gabapentin or pregabalin, may be very useful analgesics in mul-
timodal analgesia for the management of acute postoperative pain (Rorarius et al. 
2004). Pregabalin have shown to have a significant opioid sparing and analgesic 
effect in a number of surgical settings postoperatively (Fassoulaki et al. 2006; Tiip-
pana et al. 2007; Agarwal et al. 2008; Freedman and O’Hara 2008; Jokela et al. 
2008a; Jokela et al. 2008b; Mathiesen et al. 2009; Gilron et al. 2009; Burke and 
Shorten 2010; Buvanendran et al. 2010;). In many studies, pregabalin has been 
administered only as a single dose before surgery. There are also many studies, 
in which gabapentinoids were not found to be beneficial in the management of 
acute postoperative pain (Agarwal et al. 2008; Jokela et al. 2008b; Mathiesen et 
al. 2009). Dauri et al. have published a systematic-narrative review of the clinical 
studies, where gabapentin and pregabalin have been used for acute postoperative 
pain management: they concluded that both, gabapentin and pregabalin reduced 
pain and opioid consumption after surgery on confront with placebo. However, 
42
more randomised clinical trials (RCTs) are needed to compare gabapentinoids with 
other postoperative regimens and to study for a longer postoperative period (Dauri 
et al. 2009). The optimal dose and duration of the postoperative treatment with 
gabapentioids are not clear. 
5.11.3. pregabalin for aCute pain in adults after CardiaC surgery
Although gabapentinoids have been studied widely in clinical analgesia studies 
(Tiippana et al. 2007; Dauri et al. 2009), there is very little information on their 
use after cardiac surgery and in elderly patients. The effect of gabapentinoids on 
postoperative pain after cardiac surgery and in the elderly is still unclear. A single 
dose of gabapentin was reported to reduce morphine consumption and postopera-
tive pain in middle-aged patients after cardiac surgery (Menda et al. 2010). However 
in contrast, another recent clinical study reported, that preoperative gabapentin 
followed by postoperative dosing for two days did not affect postoperative pain, 
sleep, or opioid consumption after cardiac surgery (Rapchuk et al. 2010). Parlow 
et al. have shown that plasma gabapentin concentration was unaltered during CPB 
following preoperative administration (Parlow et al. 2010).
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Aims of the study
6. aims oF tHe study
The main purpose of the present work was to investigate the measurement and the 
management of pain in patients suffering various stages of cognitive impairment, 
patients in long term hospital care, and cognitively normal elderly Finnish patients 
after cardiac surgery.
The specific aims were:
1.  To evaluate the correlation between pain intensity, daily activities, 
cognitive state, depression and their interrelationship in home-dwelling 
elderly people with chronic pain (I).
2.  To evaluate the usefulness of four simple pain scales in cognitively 
impaired patients in long term hospital care and cognitively normal 
patients (II-III). 
3.  To investigate the association of opioid effects and plasma concentrations 
of fentanyl and oxycodone between elderly and middle-aged patients after 
cardiac surgery (IV).
4.  To study the influence of pregabalin on consumption of oxycodone, 







This study was performed in Oulunkylä Rehabilitation Hospital in Helsinki (study 
I), in the department of geriatrics in Katriina Hospital, Vantaa (study II) and in 
the departments of Anaesthesiology and Intensive Care Medicine and in the de-
partments of Cardiothoracic Surgery (studies III-V), Helsinki University Central 
Hospital, between  February 2002 and  August 2009.  The study protocol of study 
II was approved by the local Ethics committee of Katriina Hospital in Vantaa. 
The protocols for studies I and III-V were approved by the Ethics Committees of 
Helsinki University Central Hospital. All patients were informed about the purpose 
of the study before participating in the study. The patients or their relatives gave a 
written informed consent. The total number of patients was 366 (178 females and 
188 males). The mean age of patients was 77 years (SD ± 8; figure 1). The young-
est patient of these studies was 32 years old and the oldest patient was 96 years 
old. The oldest cardiac surgery patient was 91 years. Exactly 60 patients suffered 
chronic pain and 300 patients suffered acute pain. Twenty orthopaedic patients 
and 280 cardiac surgery patients participated these studies I-V (Table 2). Seven 
patients (2%) refused to participate in the studies.
Figure 1. Histogram of patients age in studies i-V.
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Study I-II
Study I was performed on war veterans participating in 2-week government-sup-
ported rehabilitation programs for various disabilities and pain. The subjects were 
home-dwelling citizens and during the program they stayed in a patient hotel at-
tached to the institution, Oulunkylä Rehabilitation Hospital, Helsinki. The subjects 
for this pain study were selected from those who had reported moderate or strong 
pain as part of their need for rehabilitation in the admission charts.
Patients were recruited from the geriatric department (201 beds) of the primary 
health care hospital Katriina (Vantaa City, Finland).  Forty-five long-term care pa-
tients (76-95 years, 5 males, 40 females) were selected based on signs or symptoms 
that indicated the presence of pain.  
Study III-V
Exactly 160 Finnish-speaking patients, aged over 65 years, were studied after car-
diac surgery in study III. Patients older than 65 years undergoing elective coronary 
by-pass (CABG) or valvular repair were allocated by turns into two groups, the red 
wedge scale (RWS n = 80) or the facial pain scale (FPS n = 80) group at random 
according to the operation number of  the clinical computer list one day before the 
preoperative visit. The exclusion criteria for this study were dementia and cogni-
tive impairment. The patients were autonomous perioperatively, non-hospitalized 
and able to carry on their daily routines. They were scheduled to undergo elec-
tive CABG with cardiopulmonary bypass (CPB) or with a beating heart (off-pump) 
technique or valve repair surgery with CPB. A standard median sternotomy was 
used in all patients and postoperative drainage tubes were inserted according to 
accepted clinical practice.
Exactly 30 patients aged over 75 years and 20 patients under 60 years, scheduled 
for elective CABG with CPB or for valve surgery with CPB, were enrolled in study 
IV. Patients were excluded if they presented with a left ventricular ejection fraction 
(EF) of less than 35%, acute or chronic renal insufficiency (plasma creatinine level 
> 150 µmol/l), liver disease, neurologic disease (with the exception of past transient 
ischaemic attack), as well as patients scheduled for emergency reoperation due to 
haemorrhage. Those exclusion criteria were chosen to allow for the exclusion of 
high-risk patients for prolonged postoperative intubation in the ICU.
Study V initially included 70 patients, 75 years or older, scheduled for primary 
elective CABG with CPB or single valve repair or replacement with CPB. Exclusion 
criteria included left ventricular EF of less than 30%, acute renal failure or a history 
of chronic renal insufficiency (plasma creatinine level > 150 µmol/l), a history of 
liver disease, congestive heart failure, type I diabetes mellitus, neurological disease 
other than transient ischemic attack (TIA), preoperative infections, obesity; body 
mass index (BMI) of more than 35, psychiatric disease or alcohol abuse, chronic 
pain syndrome, and recent use of gabapentinoids. These criteria were chosen to 
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exclude high-risk patients who would require prolonged intubation and, therefore, 
would not be able to complete the study protocol (study V/ Fig. 1)
table 2. summary of the demographic and clinical data of patients
7.2. methods
7.2.1. pain measurement tools 
In studies I-V, the 5-point VRS (Melzack 1975) was used as the scale for pain as-
sessment. In studies I-III, pain was evaluated and measured by the VAS (Scott 
and Huskisson 1976). In studies II-IV, the 50-cm red-coloured horizontal RWS 
scale (Tigerstedt and Tammisto 1988; Tarkkila and Saarnivaara 1999; Silvasti and 
Pitkänen 2001; Leino et al. 2011) was used for the measurement and evaluation of 
postoperative pain. In studies II-III, an FPS modified to a 7-point scale (excluding 
tearfulness; Bieri et al. 1990) was used to evaluate pain in demented patients and 
in cognitively normal cardiac surgery patients.
7.2.2. mCgill pain questionnaire (mpq) and  
minimum data set questionnaire 
Study II
Pain intensity was measured by using all four pain scales three times at 2-week 
intervals, at rest and during movement with reassessment ten minutes later. The 
subjects expressed the location of their pain and the movement which induced the 
worst pain. Patients were assessed once, before the first pain tool test, using the 
Finnish version (Ketovuori et al. 1984) of  the McGill pain questionnaire (PQ). The 
	 study i  study ii  study iii  study iV  study V
 (n = 41) (n = 45) (n = 160) (n = 50) (n = 70) 
Age	(years)	 79	±	4	 84	±	5	 73	±	5	 69	±	14	 80	±	4
Female/Male	 4	/	37	 40	/	5	 80	/	80	 21	/	29	 33	/37
Height	(cm)	 174	±	8	 -	 167	±	9	 168	±	10	 166	±	9
Weight	(kg)	 80	±	13	 -	 75	±	13	 76	±	14	 74	± 12
Pain	scale	 VRS,	VAS	 VRS,VAS	 VRS,VAS	 VRS	RWS	 VRS
	 	 RWS,	FPS	 RWS,	FPS
	 	 PQ
MMSE	(0–30)	 25	±	3			 16	±	8	 -	 -	 29	±	2
GDS	(0–15)	 5	±	3	 	 -	 -	 -
Barthel	Index	(0–100)	 87	±	13	 -	 -	 -	 -
Acute	pain	(n)	 -	 20	 160	 50	 70
Chronic	pain	(n)	 41	 25	 -	 -	 -
Type	of	surgery
	 Cardiac	 -	 -	 160	 50	 70
	 Orthopaedic	 -	 20	 -	 -	 -
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nurses of the department gave their observational estimate of the severity (VRS) 
and incidence (0 = no pain, 1 = quite rarely, 2 = daily) of pain at the time of each 
of the three testing sessions by using pain estimates of the Minimum Data Set 
questionnaire (Finne-Soveri and Tilvis 1998a).
figure 2. pain measurement tools 
7.2.3. determination of the CognitiVe status
Studies I-II and V
The cognitive status of patients was first determined by using the mini-mental state 
examination (MMSE) in studies I-II and V(Folstein et al. 1975). Thirty points was the 
maximum score. Only patients who were not strongly impaired cognitively (MMSE 
> 17) were allowed to take part in our assessment because of the assumption that 
such patients are likely to be able to perform the pain tests included in our protocol 
in study I. The mental status of the patients in study II was assessed once before 
the first pain tests. Cognitive status of the patients in study V was assessed before 
operation and on the fifth postoperative day after cardiac surgery.
7.2.4. determination of the depression
Studies I-II
For the determination of the degree of depression in the studies I-II, we used a test 
especially designed to detect depression in older people, the geriatric depression 



















yes-no items. The maximum score is 15 points, and the higher the score the greater 
the likelihood of depression.
7.2.5. determination of the funCtional ability in the daily life
Study I
The functional ability in the daily life of the patients in Study I was determined by 
using the Barthel Index (Mahoney and Barthel 1965; Granger et al. 1979a; Granger 
et al. 1979b; Reed and Gessner 1979). One hundred points is the maximum score 
in the Barthel Index test. The higher the score the better are the functional daily 
activities of the patient. 
7.2.6. proCedure of pain measurement in studies i-V (figure 2, table 3)
7.2.6.1. Community elderly in study I
Two pain scales were used to assess the intensity of pain, the VRS and the VAS. 
Both of these scales and the methods of assessment were meticulously described 
to each patient, several times as needed, until it was clear that the methods were 
understood. The scores on VRS were 0 “no pain”, 1 “slight pain”, 2 “moderate pain”, 
3 “considerable pain” and 4 “extreme pain” (Keele 1948; Banos et al. 1989). A stand-
ard 10 cm line was used as the VAS (Keele 1948; Scott and Huskisson 1976), with 
0 if there was no pain and 10 if the pain was the worst imaginable by the patient. 
The severity of pain was first scored at rest (rest pain) by using VRS and VAS. Then 
the intensity of pain was determined with these tests after a particular movement 
of a limb or the trunk, or after a short distinct exercise, which the patient knew 
would provoke an increase in pain intensity (manipulation pain). All tests on an 
individual person were performed on the same day. 
7.2.6.2. Demented patients in study II
Pain was measured 3 times at 2 week intervals by VRS, VAS, RWS, and FPS (Table 
2). In order to rule out any influence of the previous pain measurements on the 
ongoing pain measurement, the patients were also asked to try to recall the severity 
of the pain in the 2-week period between measurements.  In addition, the nurses of 
the department gave their observational estimate of the severity (VRS) and incidence 
(0 = no pain, 1 = quite rarely, 2 = daily) of pain  at the time of each of the three 
testing sessions by using pain estimates of the Minimum Data Set questionnaire 
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(Finne-Soveri and Tilvis 1998b). The pain measurements were performed during 
the day. During the study period the patients received their usual pain medication. 
The time from the last intake of pain medication and the performance of the tests 
was not standardized.
7.2.6.3. Cardiac surgery patients in studies III-V
Study III
The pilot study suggested that after major surgery elderly patients become easily 
exhausted and are unable to reliably complete more than three pain measurement 
scales during one session. Thus, in addition to either RWS or FPS grouping, the 
patients were assessed by using both the 5-step VRS and 10-cm VAS (Table 2). The 
patients were studied daily for the first four days after tracheal extubation. They 
were provided with their eyeglasses and their false teeth prior to undergoing the pain 
measurements. The interview technique was standardized: before every measure-
ment, the scale was shown to the patient and the terms (no pain – worst possible 
pain) were explained. Pain was assessed by always using the same words and the 
evaluation was made at rest and during movement (coughing or deep breathing). 
Each assessment of RWS and FPS was repeated after ten minutes. The pain scales 
were used in all the assessments in a similar order, that is, VRS, VAS, RWS or FPS. 
Reasons for unsuccessful measurements were recorded during the study: the 
measurement was deemed unsuccessful if the patients failed to understand the tes-
ting tools. The failure measurements with VRS were as follows: a. if the patient was 
unable to understand questions regarding pain intensity and was unable to express 
the level of the pain intensity with words (0=no pain, 1=slight pain, 2=moderate 
pain, 3=severe pain 4=unbearable pain), b. The measurement with VAS, RWS and 
FPS was taken as failed, when the patient could not demonstrate their level of pain 
intensity on the scale. To evaluate the effect of age of compliance to pain measu-
rement, the patients were further divided into two groups each according to their 
age: 65-74 and 75 years or more.
Study IV
After extubation, when the patient requested analgesia, pain intensity was meas-
ured using both the Verbal Rating Scale (VRS) and a visual 50-cm Red Wedge 
Scale (RWS). When the patients of study IV had postoperative pain (VRS ≥ 2, or 
RWS ≥ 20 cm), blood samples for the determination of the plasma concentration 
of fentanyl and oxycodone were taken. Pain intensity was measured regularly using 




Early postoperative pain in the ICU
Pain intensity was recorded every second hour during the first 24 hours after extu-
bation in the early postoperative period. In the ICU, 1 g of paracetamol was given 
intravenously as an analgesic two hours after the operation and three times daily 
thereafter. In the ICU, before extubation, intravenous oxycodone 0.05 mg kg-1 was 
given, as clinically indicated. When the patient expressed moderate or stronger pain 
(VRS ≥ 2), oxycodone was administered intravenously in the ICU (0.05 mg kg-1), 
or orally (0.10-0.15 mg kg-1) or intramuscularly (0.1 mg kg-1) on the ward.
Postoperative pain 1 and 3 months after the cardiac surgery
Paracetamol was used for the treatment of postoperative pain at home. The inci-
dence of postoperative pain was assessed by a telephone interview in which the 
VRS pain score at rest and during movement and the analgesics consumed were 
recorded one and three months after the surgery.
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table 3. pain measurement protocols of studies i-V
Pain scales Patient Pain measurement of pain Period of pain measurement amount of measurement study design
study i  





















































7.3. anaesthesia and monitoring during  
CardiaC surgery
Studies IV -V
Patients received general anaesthesia without epidural analgesia, or local anaes-
thetics injected into the wound. All regular scheduled cardiac medications were 
administered to the patients on the morning of surgery. Patients were medicated 
with oral lorazepam (1-4 mg). Anaesthesia was induced with intravenous opioids 
followed by propofol or etomidate, and rocuronium or pancuronium was used to 
provide muscle relaxation. Anaesthesia was maintained with continuous infusions 
of propofol and fentanyl or sufentanil along with isoflurane or sevoflurane. The 
bispectral index (BIS) was monitored to achieve an optimal level of anaesthesia, 
keeping the BIS-value between 40 and 60.
CPB was performed with a roller pump, membrane oxygenator and a non-co-
ated circuit. Non-pulsatile pump flow was maintained at 2.4 L·min-1·m-2 and cold 
blood cardioplegia was used for myocardial protection. CBP was performed under 
moderate hypothermia (core temperature 32-34ºC). PaCO2 was kept within the 
normal values according the alpha-stat principle. The revascularization procedure 
of off-pump CABG was performed on the beating heart with a stabilization of the 
target coronary arteries. When access to posterior coronary arteries was required, 
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Pain scales Patient Pain measurement of pain Period of pain measurement amount of measurement study design
study i  





















































a suction device was used to lift the heart. Intraoperative temperatures were me-
asured with a pulmonary artery thermodilution catheter, from the urinary bladder 
and the nasopharyngx .
7.4. protoCol of study iV, the administration of  
opioids and sampling 
An arterial blood sample for the measurement of the plasma concentration of fen-
tanyl was taken at the time when the intravenous-fentanyl infusion was stopped, 
and the second sample two hours later.  
When the patients experienced pain after tracheal extubation (VRS ≥ 2 or RWS 
≥ 20 cm), blood samples for the determination of the plasma concentration of fen-
tanyl and oxycodone were taken. Immediately thereafter, oxycodone hydrochloride 
(0.05 mg/kg) was administered intravenously (= oxycodone test 1). Pain intensity 
and plasma concentrations of oxycodone were assessed 15 and 45 minutes after 
oxycodone administration. This oxycodone test was performed three times for each 
patient during their stay in the ICU (fig.1 /study IV) and the time interval between 
them was recorded.  
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7.4.1. determination of fentanyl and oXyCodone ConCentrations  
in plasma
Chemicals and reagents
Fentanyl citrate was purchased from Janssen Research Foundation (Titusville, 
NJ, USA) and nalorphine (internal standard) from Sigma-Aldrich Chemie Gmbh 
(Steinheim, Germany). Oxycodone hydrochloride was obtained from Santen Oy 
(Tampere, Finland). All reagents were of the highest quality.
Measurements of fentanyl and oxycodone concentration
Frozen plasma samples were thawed overnight at +5ºC. Sample preparation was 
carried out as follows: fentanyl and oxycodone were extracted from a 1-ml aliq-
uot of the sample by mixing with 1 ml of buffer (0.5 M Na2HPO4 ∙ 2 H2O) and 
5 ml of toluene (containing 0.08 µg/ml of nalorphine as the internal standard). 
After centrifugation, the toluene layer was transferred into a clean test tube and 
evaporated to dryness in a vacuum evaporator. After dissolving the residue in 48 
µl of butyl acetate, 12 µl of the derivatization reagent, N-methyl-N-trimethylsilyl-
trifluoroacetamide (MSTFA) was added. Then, a 2-µl aliquot of the sample was 
injected into a gas chromatograph-mass spectrometer (GC-MS) (Hewlett-Packard 
Company, Palo Alto CA, USA) (EI, positive ions, 70 eV). The system was operated 
in the splitless injector mode. The DB-200 GC column was 30 m in length, had 
internal diameter 0.32 mm, and film thickness 0.25 (J&W Scientific Inc., Folsom, 
CA, USA). Helium was the carrier gas. The column temperature was initially 120ºC 
with a hold time of 0.5 min, and it was increased 15ºC/min, with a final hold time 
of 1 min at 340ºC. The inlet and MSD transfer line heater temperatures were main-
tained at 250ºC and 300ºC, respectively. MS detection was performed in selected 
ion monitoring (SIM) mode. Target masses were m/z 455 for nalorphine, m/z 245 
for fentanyl and m/z 495 for oxycodone.
No interfering peaks were detected in blank plasma samples. The lower limits 
of quantitation were set at 1.0 ng/ml for fentanyl and 2.0 ng/ml for oxycodone. At 
a concentration of 50 ng/ml, repeatability (relative standard deviation, RSD) was 
7% for fentanyl and 11% for oxycodone, and time-different intermediate precision 
(RSD %) was 11% for fentanyl and 22% for oxycodone. Accuracy, expressed as 
percentage bias, was 3% for fentanyl and 8% for oxycodone.
7.5. protoCol of study V
Patients were premedicated orally one hour before surgery with lorazepam (0.02-
0.03 mg kg-1) and the study drug, pregabalin 150 mg (Lyrica® 75 mg capsule, 
Pfizer GmbH, Freiburg, German) or placebo. The second dose of the study medi-
cation, either 75 mg of pregabalin or placebo was given on the first postoperative 
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day. Thereafter, the patients received either 75 mg of pregabalin or placebo twice 
daily until the fifth postoperative day. The hospital pharmacy performed the ran-
domization using a computer-generated randomization schedule. The pharmacy 
also prepared the study medication by packing pregabalin or placebo into identical 
capsules for blinding. Each consenting patient received the study drug according to 
a consecutive randomization number, which was labeled to opaque plastic contain-
ers containing the study drugs. 
7.6. postoperatiVe Care after CardiaC surgery
Studies III-V
Propofol sedation (2-4 mg·kg-1·h-1) was continued in the ICU, where analgesia was 
provided using paracetamol 1g intravenously. This dose was repeated every eight 
hours and, when needed, oxycodone in doses 0.05 mg·kg-1 was intravenously in-
jected. Sedation was discontinued, when the central temperature reached 36ºC. 
The tracheal tube was removed, when the patient was able to respond to verbal 
command and fulfilled the extubation criteria according to our clinical practice. 
Criteria for extubation included a responsive and cooperative patient, no uncon-
trolled arrhythmia, haemodynamic instability, or excessive chest tube drainage, 
FiO2 below 40%, pH over 7.3, and core temperature over 36.5°C, spontaneous 
respiratory rate less than 20 breaths/min and respiratory rate of the ventilator set 
at less than 2/min. The positive end-expiratory pressure was set at 6 cm H2O. The 
majority of patients were extubated after 6-8 hours in the ICU.  When the patients 
did not need intensive care any more, they were transferred from the ICU to their 
surgical ward where they were given paracetamol 1g orally three to four times daily 
and oxycodone 0.1 mg·kg-1 intramuscularly or 0.2 mg.kg-1 orally, as needed. 
7.7. Consumption of opiods after CardiaC surgery in 
studies iii-V
In study III, the mean daily dose of intravenous oxycodone was recorded in both 
study groups in the ICU period. In study IV, the mean total intravenous dose of 
oxycodone and the mean total dose of infused fentanyl were recorded before tracheal 
extubation. In study V, total parenteral oxycodone consumption before tracheal 
extubation and thereafter as long as the patients stayed in the ICU were recorded. 
Total parenteral oxycodone consumption was determined during the first 16 hours 
after extubation. The total cumulative oxycodone consumption and orally admin-
istered oxycodone doses during the first five postoperative days were recorded.
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7.8. measurement of postoperatiVe sedation and  
Confusion after CardiaC surgery
Study IV 
Postoperative sedation was registered on the Ramsay sedation scale (Ramsay et 
al. 1974). The levels 1-6 are: 1 = patient is anxious and/or agitated, 2 = patient 
is co-operative, oriented and tranquil, 3 = patient responds to command only, 4 
= patient responds briskly to light glabellar tap or auditory stimulus, 5 = patient 
responds sluggishly to tap or auditory stimuli, 6 = patient does not respond to tap 
or auditory stimuli. The degree of sedation was assessed concurrently with the pain 
intensity measurements. 
Study V 
Sedation scores were recorded every second hour during the first 16-24 hours after 
extubation or as long time as the patients stayed in the ICU. Postoperative sedation 
was measured with the Richmond Agitation Sedation Score (RASS) (Sessler et al. 
2002).  The scores from 0 to 9 are: 0 unarousable, 1 deep sedation, 2 moderate 
sedation, 3 light sedation, 4 drowsy, 5 alert and calm, 6 restless, 7 agitated, 8 very 
agitated, 9 combative. The degree of postoperative confusion was rated with the 
modified Confusion Assessment Method for the ICU (CAM-ICU) once daily during 
the first five postoperative days after extubation (Ely et al. 2001) The highest score 
of the modified CAM-ICU test was 25 that indicate no confusion. 
7.9. failure of the pain measurement sCales after 
CardiaC surgery in study iii
The reasons for unsuccessful pain measurements were recorded after every pain 
measurement in cardiac surgery patients of study III/Table3. 
7.10. reCording of side-effeCts; nausea, Vomiting,  
sedation, and Confusion after CardiaC surgery  
in studies iV-V
In study IV-V, nausea, vomiting and sedation were recorded every second hour 
during the first 16-24 hours after extubation or as long time as the patients stayed 
in the ICU. In study V, postoperative nausea and vomiting were registered by ask-
ing the patients to select one of the following descriptors: 0 = no nausea, 1 = slight 
nausea, 2 = moderate nausea and 3 = severe nausea. Ondansetron (4 mg i.v.) was 
given, when the patient had nausea or vomited. 
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The degree of postoperative sedation was registered with RASS (study IV) and 
Ramsay score (study V) according to study protocols concurrently with pain intensity 
measurements.  Haloperidol (2.5 mg i.v.)  was given, if the patient had remarkable 
signs or symptoms of confusion. According to our clinical protocol, these side effects 
were recorded also in the ward, where haloperidol or ondansetron was given, if the 
patients had confusion or vomiting. The total consumption of ondansetron and 
haloperidol were recorded at the end of the care in the ICU and at the end of the 
fifth postoperative day in study V. The degree of confusion was measured with the 
modified CAM-ICU scores once per day during five postoperative days after surgery.
7.11. length of stay in the iCu in elderly patients after 
CardiaC surgery in studies iii-V 
The mean length of stay in the ICU was recorded in studies III-IV. 
7.12. statistiCal methods 
Descriptive data were presented as mean ± standard deviation (SD), or median and 
range or inter-quartile rage (IQR). Patients’ characteristics and clinical data were 
analyzed between the two study groups by paired t-test or Wilcoxon signed rank 
test for independent samples in studies I-V. Fisher´s one-sided Z-transformation 
was used to compare correlation coefficients in study I. The correlations between 
parameters were assessed using the nonparametric Spearman rank order correlation 
(Sigma Stat, for windows, Chicago, IL, U.S.A) in studies I-II. Also the Spearman 
rank order correlation was used to determine the consistency of the assessment 
using the four different scales, and correlation between the evaluations provided 
by the nurses and the pain intensity for each patient (Sigma Stat, for windows, Chi-
cago, IL, U.S.A) in study II. The number of successful pain measurements between 
study groups for each measurement type was compared with the Cochran test in 
study III. In studies II, IV-V, the cases of the several groups were compared using 
analysis of variance (ANOVA) for  repeated measures (Freidman´s test, study II) 
followed one-way ANOVA and a post-hoc test (Bonferroni, study II) (Tukey´s LDS 
test, studies IV-V). Statistical analyses were performed using SPSS for Windows v. 
12.1 (SPSS Ltd, Chicago, Il, U.S.A) in study III.-V.  If the P value was smaller than 
0.05, the correlation between factors was considered to be statistically significant.
table 4. patient characteristics and intraoperative data (mean ± sd), median (range) 
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8.1. demographiC and anaesthesia data of the  
patients in studies i-V
Patient characteristics and clinical data are presented in Table 4. The total number 
of pain measurements was approximately 8364 in studies I-V (Table 5). Approxi-
mately 40% of pain assessments were measured with the VRS, which was used in 
all studies. 
table 5. total number of pain measurements in studies i-V.
8.2. results of pain measurements in CognitiVely  
impaired and dementia patients (studies i-ii)
Exactly 1244 pain measurements were made with four different pain scales in cog-
nitively impaired and demented patients in studies I-II (Table 5). The mean and 
the median of the patients’ pain intensity in cognitively impaired and demented 
patients at rest were mild as measured by the VRS, the VAS, the RWS, and the 
FPS. The pain intensity with movement was moderate in studies I-II (Table 6).
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      8. RESULTS 
8.1. Demographic and anaesthesia data of the patients in studies I-V 
Patient characteristics and clinical data are presented in Table 4. The total number of pain 
measurements was approximately 8364 in studies I-V (Table 5). Approximately 40% of pain 
assessments were measured with the VRS, which was used in all studies.  
 
      Table 5. Total number of pain measurements in studies I-V. 
 
                      
                  Total number of pain 
Study     Patients  VRS VAS RWS FPS     measurement per study 
_______________________________________________________________________________ 
 
   I          (n = 41)    82     82                  164        2.0% 
  II          (n = 45)  270   270   270   270       1080      12.9% 
  III        (n = 160)         1280 1280 1280 1280     5120      61.2% 
  IV         (n = 50)  300    300                 600       7.2% 
   V         (n = 70)           1400                1400     16.7% 
_______________________________________________________________________________ 
Total number of 3332  1632 1850 1550 8364                                                                                      
pain measurement  40.0% 19.5% 22.0% 18.5%             
per pain scale      
   
 
 
8.2. Results of pain measurements in cognitively impaired and dementia patients (studies I-II) 
Exactly 1244 pain measurements were made with four different pain scales in cognitively impaired 
and demented p tients in studies I-II (Table 5). The mean an  the median of the patients’ pain 
intensity in cognitively impaired and demented patients at rest were mild as measured by the VRS, 






table 6. summary of intensity of pain on pain scales Vrs, Vas, rws and fps at 
rest and movement in studies i-ii.
8.2.1. pain sCales Validity in Community-dwelling elderly and  
demented patients (studies i-ii)
Pain measurements with VRS and VAS scales at rest and movement correlated 
positively with each other in community-dwelling elderly. Spearman correlation 
coefficients between the VRS and the VAS changed from r = 0.351 to r = 0.78 (P < 
0.001) in Study I. All four pain scales correlated with each other at rest and move-
ment (r = 0.392 - 0.850, P < 0.001) in demented patients in study II.
8.2.2. CognitiVe funCtion, degree of depression and aCtiVities of 
daily life (study i)
The mean MMSE-score of the elderly in community-dwelling was 25 ± 3, the mean 
score on the GDS was 5 ± 4 points and the mean Barthel Index was 87 ± 13 (Table 
2). VRS pain scores after movement correlated positively with the Barthel Index 
while VAS scores did not. The positive correlation between VRS pain scores after 
movement and Barthel Index was significantly different from the correlation be-
tween Barthel Index and pain at rest scored with VRS (Z = -2.152, P < 0.05) or 
VAS (Z = -2.952, P < 0.01) in study I.
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Table 6. Summary of intensity of pain on pain scales VRS, VAS, RWS and FPS at rest and 
movement in studies I-II. 
        Study I                 Study II    
Pain scale      (n = 41)                (n = 45)   
_________________________________________________________________________ 
      Mean (SD) Median Range                Mean (SD) Median Range     
       VRS (0-4)         
 at rest        1.0 ± 0.9  *   1       (0 - 3)                                      1       (0 – 2) 
 during movement   2.8 ± 0.9 *   3       (1 - 4)                                             2       (2 – 3) 
 
      VAS (0 -100) (mm) 
at rest          29 ± 24 *    20      (0 – 80)                   23 ± 0.5 
during movement   75 ± 23  *   80    (30 -100)                  59 ± 0.6 
 
      RWS (0-50) (cm) 
at rest                          13.7 ± 2.5  
during movement                                        31.1 ± 2.6  
 
      FPS (0-6)      
at rest                                                 2    (0 - 4) 
during movement                                                            4    (3 – 6)  
_________________________________________________________________________ 
      Study I:   The difference in pain intensity at rest and after movement  (* P< 0.001, paired test)    
 
8.2.1. Pain scales validity in community-dwelling elderly and demented patients (studies I-II) 
Pain measurements with VRS and VAS scales at rest and movement correlated positively with each 
other in community-dwelling elderly. Spearman correlation coefficients between the VRS and the 
VAS changed from r = 0.351 to r = 0.78 (P < 0.001) in Study I. All four pain scales correlated with 
each other at rest and movement (r = 0.392 - 0.850, P < 0.001) in demented patients in study II. 
 
8.2.2. Cognitive function, degree of depression and activities of daily life (study I) 
The mean MMSE-score of the elderly in community-dwelling was 25 ± 3, the mean score on the 
GDS was 5 ± 4 points and the mean Barthel Index was 87 ± 13 (Table 2). VRS pain scores after 
movemen  correlated positively wi h the Barthel I dex while VAS scores did not. The positive 
correlation between VRS pain scores after movement and Barthel Index was significantly different 
61
Results
GDS correlated positively with pain estimates given with the VRS method at 
rest, but not with the VAS scores at rest. After a pain-provoking movement neither 
VAS nor VRS pain scores correlated with GDS. Analogously, correlation coefficients 
between GDS and pain scored with VRS or VAS after movement were significantly 
different from the correlation coefficient between GDS and pain scored with VRS 
at rest (in both cases Z = 1.72, P < 0.05, Fisher’s Z-transformation). Correlation 
coefficients between GDS and pain scored with VRS or VAS after movement did 
not differ from the correlation coefficient between GDS and pain scored with VAS 
at rest (study I).
8.2.3. Correlations between mmse, gds, barthel indeX and pain sCores
The Barthel Index correlated positively with the MMSE-score and negatively with 
GDS. Correlation between Barthel Index and GDS differed significantly from the 
correlation between Barthel Index and VRS pain scores at rest (Z = -1.689, P < 0.05), 
and from the correlation between Barthel Index and pain scores after movement 
measured with VAS (-2.679, P < 0.01)  or  VRS (Z=-3.841, P < 0.001). Correlation 
between MMSE and the Barthel Index differed from correlations between the Bar-
thel Index and rest pain measured with VAS (Z=2.63, P < 0.01) or VRS (Z=1.829, 
P < 0.05) in study I. 
8.2.4. mmse sCores and pain measurements in demented patients 
(study ii)
The higher the MMSE scores (24-30), the better the patients were able to use the 
pain scales for reporting their pain. However, even slight cognitive impairment 
(MMSE 17-23) induced difficulties in using RWS, VAS and FPS. Moderately (MMSE 
11-16) and severely (MMSE ≤ 10) demented patients could report better the severity 
of pain using the VRS method in comparison with the others: in the patients with 
the lowest MMSE (≤ 10), the success rate of measurement with the RWS was less 
than 26%, on average. The antipsychotic drugs were used more in the group of the 
lowest MMSE ≤ 10 as compared to the other groups (P < 0.05).   
8.2.5. the seVerity and inCidenCe of pain estimated by nurses (study ii)
The severity and incidence of pain in demented patients estimated by nurses did 
not correlate consistently with the patients’ magnitude of pain measured with the 
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four tools.  However, in all three sessions, the nurses’ estimates of the intensity of 
the patients pain correlated positively with their own estimates of the incidence of 
patient’s pain  (r = 0.474-0.515, P < 0.01) in Study II.  
8.3. eValuation of pain sCales and pain intensity in 
elderly patients after CardiaC surgery (studies iii-V)
Exactly 7120 pain measurements with four different pain scales were performed in 
elderly patients after cardiac surgery (Table 5). Pain intensity was mostly mild at 
rest and the maximal pain intensity was usually assessed as moderate after cough-
ing during the first three days for all pain scales (VRS, VAS, RWS, FPS) in study III 
(Table 7). The incidence and intensity of early postoperative pain measured with 
VRS within 24 hours after extubation in studies IV-V is shown in Table 8. Incidence 
of moderate pain altered from 4 to 39% in elderly patients and from 10 to 40% in 
middle-aged patients during the early postoperative period after cardiac surgery in 
studies IV-V (Table 8). Pain intensity was primarily measured just before or after 
analgesic. The applied clinical protocols for postoperative pain management were 
consistent for studies III-V.
8.3.1. assessment of pain after CardiaC surgery in elderly patients 
(studies iii-iV)
The failure rate of pain measurement was the highest for all the scales during the 
first two postoperative days after tracheal extubation. The percentages of successful 
pain measurements were VRS 87%, 10-cm VAS 62%, RWS 76% and FPS 60% on 
the first day after tracheal extubation. The patients succeeded with all pain scales 
better during the following next three days. The most common reasons for the un-
successful measurements were postoperative confusion, exhaustion and difficulties 
to interpret the scales. The higher age decreased the successful pain measurements. 
In the group over 75 years of age (≥ 75 years), VRS (81%) and RWS (83%) scales 
were used most reliably. During the first day after extubation, the pain measurement 
with 10-cm VAS succeeded in 60% of the patients with FPS in only 44% of cases.
The reasons for elderly pain-measurement failures were postoperative confusion, 
exhaustion, delirium, or unwillingness to answer after cardiac surgery (study III). 
The use of the VRS was successful in 99% of the pain measurements for the older 
(≥ 75 years) and the younger (≤ 60 years) groups in study III. The percentage of 
the successful pain measurements during study III with RWS was 69% in the older 
group and 95% in the younger group.
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8.3.2. pain sCales Validity in the elderly after CardiaC surgery 
(study iii)
Spearman correlations included 16 pairs between successful measurement with the 
RWS and the FPS pain scales and the control pain scales with the VRS and the VAS 
in study III. All pain scales at each rating correlated well over the four day assess-
ment period. Pain measurement with the RWS correlated with the VAS (r = 0.758, 
P < 0.001) and a weaker correlation was seen between the RWS and the VRS (r = 
0.666, P < 0.001). There was also a good correlation between the measurements 
with FPS and the VAS (r = 0.873, P < 0.001) and weaker correlation with the VRS 
was found (r = 0.583, P < 0.001). There was also a good correlation between the 
initial measurement and the second measurement that followed the 10 min rest 
period ((r = 0.898-1.00, P < 0.001).
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table 7. results of assessment of pain scales in elderly patients after cardiac 
surgery (study iii) Pain intensity at rest and during movement, after coughing or 
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table 8. the percentage of patients with different levels of pain intensity measured 
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8.4. the ConCentration of fentanyl after CardiaC 
surgery (study iV)
At the end of surgery and two hours later, the mean plasma concentrations of 
fentanyl were significantly higher in the older patients than in the younger ones (P 
<0.05). Fentanyl was still detected in the plasma of some patients after extubation 
at the time of beginning the first oxycodone test, with concentrations of 1.43 ± 0.94 
ng/ml in the older group (n = 12/30) about 12 hours after the end of the fentanyl 
infusion, and correspondingly 1.36 ± 0.67 ng/ml in the younger group (n = 8/20) 
about 10 hours after the end of the fentanyl infusion. 
8.5. oXyCodone administration after CardiaC surgery 
in studies iV-V
Study IV
Prior to tracheal extubation in the ICU, the mean cumulative oxycodone dose was 
9.3 ± 4.9 mg in the older group (≥ 75 years) and 11.5 ± 6.4 mg in the younger group 
(≤ 60 years) (NS). The mean plasma concentrations of oxycodone with the three 
tests were not statistically different between the older and the younger groups. The 
time interval between the first and second oxycodone test was similar between the 
groups, but the interval between the second and third oxycodone test was signifi-
cantly longer in the older group (263 ± 160 min) than in the younger group (182 
± 78 min)  (P < 0.05). 
Study V
Mean cumulative parenteral consumption of oxycodone during the first 16 postop-
erative hours after extubation was 43% lower in the pregabalin group (8 ± 5 mg) 
compared to the placebo group (14 ± 6 mg) (P < 0.001). Mean cumulative total 
oxycodone consumption from extubation to the end of the fifth postoperative day 
was 48% lower in the pregabalin group (48 ± 28 mg) compared with the placebo 
group (93 ± 44 mg) (P < 0.001). Cumulative consumption of oral oxycodone after 
extubation to the end of the fifth postoperative day was 53% lower in the pregabalin 
group (30 ± 25 mg) than in the placebo group (64 ± 41 mg) (P < 0.001; Figure 4). 
Consumption of oral oxycodone was lower in the pregabalin group during the first 
three postoperative days. 
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Results
figure 4. effect of pregabalin in elderly patients during five postoperative days 
after cardiac surgery* p < 0.05 between the groups
8.6. leVel of sedation and postoperatiVe Confusion in 
elderly patients after CardiaC surgery 
Study III
The incidence of delirium, confusion and exhaustion varied from 7.0% to 1.4% in 
elderly patients during four postoperative days after cardiac surgery. The most com-
mon reasons for the failure of the pain measurement were postoperative confusion, 
exhaustion and delirium.
Study IV
By 15 min after administration of oxycodone (0.05 mg/kg i.v.) the degree of se-
dation was more intense in the older patients (≥ 75 years) as compared with in 
younger group (≤ 60 years) (P < 0.05). Still, after 45 min from the administration 
of an oxycodone bolus the elderly patients were more sedated than the younger 
patients (P < 0.05). There was on average a two-hour longer time to extubation 
in the older group (≥ 75 years) than in the younger patients (≤ 60 years) in study 
IV (P = NS). During the study period no patients displayed signs and symptoms 
of postoperative delirium. 
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However during their stay in the ICU, one (5%) patient from the younger group 
(≤ 60 years)  and five (17%) of the older group (≥ 75 years)  suffered from delirium. 
Study V
One patient (1%) was excluded from the study because of preoperative delirium. 
Two patients (3%) (≥ 75 years) in study V displayed delirium which prolonged 
their stay in the ICU. The sedation scores on RASS were not different between the 
groups, except at two hours after extubation, when the patients in the pregabalin 
group were less sedated than those in the placebo group (P < 0.05) (Table 9). The 
CAM-ICU confusion test score was reduced in the placebo group on the first day 
after extubation in study V (Table 10, P < 0.05). The number of patients who re-
ceived haloperidol either in the ICU or on the ward did not differ between groups.
8.7. side-effeCts, nausea and Vomiting, and Compli-
Cations in elderly patients after CardiaC surgery 
(studies iV-V)
The incidence of nausea and vomiting in elderly patients was consistent (34-37%) 
in studies IV and V after cardiac surgery. Approximately 36% of elderly patients 
and 25% of middle-aged patients suffered from postoperative vomiting in study IV, 
whilst 34% of patients in the pregabalin group and 37% of patients in the placebo 
group had postoperative nausea during the first 16 hours after extubation in study 
V. Furthermore, 31% of patients in the pregabalin group and 25% in the placebo 
group vomited during the 16 hours following extubation in study V. The incidence 
of nausea and vomiting and the number of patients receiving antiemetics did not 
differ between groups (Table 4). The incidence of postoperative stroke was 4.3% 
(3/70) in the study V. All patients with this complication were in the pregabalin 
group, where the incidence of stroke was 8.6%.
8.8. length of stay in the iCu for elderly patients af-
ter CardiaC surgery (studies iii-V)
The mean duration of stay in the ICU of the patients in studies III-V are presented 
in Table 10. Four patients from the elderly group in study IV had a prolonged 
ICU stay (> 48 hours) due to postoperative complications: one pneumonia, two 
low-output syndromes and one delirium and respiratory failure. One patient with 
unstable haemodynamic status and two patients with confusion and postoperative 
delirium stayed in the ICU for 5 postoperative days in study V.
69
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8.9. postoperatiVe pain one and three months after 
CardiaC surgery (study V)
Peri- and postoperative administration of pregabalin reduced the incidence of post-
operative pain in elderly patients at three months after cardiac surgery. Patients 
in the placebo group experienced pain during movement significantly more often 
than patients in the pregabalin group (23% vs 4%, P < 0.05).
70
table 9. patient postoperative data of sedation, postoperative confusion and vo-
miting after extubation (mean ± sd, median (range) or number of patients and p 
































































































   
   
   
   
   
   
   





































   

















   















   







   
 
   
   







   
   








   







   
   
   
   
   
   





   
   
   







   
   







































































   
   



















   
   
   
   




   
   
   
   
   
   
   
















   
   
   
   




   
   
   
   
   
   
   
















   
   
   
   





   
   







   
   
   
   













   
   
   
   




   
   
   
   
   
   
   




   
   












   
   
   
   




   
   
   
   
   
   
   




   
   













   
   
   
   




   
   



















   
   
   
   









   
   













   
   
   
   










   
   













   
   
   
   


















   
   
   











   
   
   
   










   
   
   
   
   
   
   
   
   
   












   
   









   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   











   
   









   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   











   
   








   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   











   
   




   
   
   
 
 
   
   
   
   
   
   





   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   











   
   






   
   
   
   
   
   




   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   











   
   
   
   




   
   
   
   
   
   




   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   











   
   
   
   




























   
   















   
   



















   
   
   
   
   
   
   
   
   














   
   

















   
   
   
   
   
   
   
   
   
   













   
   

















   
   
   
   
   
   
   
   
   
   













   
   

















   
   
   
   
   
   
   
   
   
   













   
   



























   
   
   
   




   
   













   
   






























































































































table 10. postoperative length of stay in the iCu and in the hospital (mean ± sd) 
for elderly patients after cardiac surgery (studies iii-V) 
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9.1. CliniCal researCh in elderly
The measurement and the management of pain in cognitively impaired patients in 
long-term hospital care and cognitively normal elderly after cardiac surgery have 
been investigated in these clinical studies I to V. The mean age of these patients 
was high, 77 years. 
In general, the elderly patients are often excluded from clinical research. Thus, 
the under-representation of older people in clinical research is accepted practice. 
This tendency lies in direct contrast to the forecast of an aging global population, 
that trends toward an older overall population in the future. Indeed, elderly people 
undergo more frequent surgeries and anaesthetic procedures than younger patie-
nts (McMurdo et al. 2005; Rooke et al. 2002; Bayer and Tadd 2000). One third 
of studies published in four major medical journals excluded older people without 
justification in 1997 (Bugeja et al. 1997). This analysis was repeated for papers 
published in the same journals in 2004. Almost 15% of papers still unjustifiably 
excluded older people, and fewer than 5% of the research published was specific 
to older people (McMurdo et al. 2005). Therefore, there is a huge difference to-
day between the real clinical world and the middle-age patients who participate 
in clinical studies. 
The elderly patients are excluded for many reasons, despite the fact that the 
elderly demonstrate a high rate of willingness to consider participation in clinical 
trials. It is well known, that the elderly may have many risk factors for drug inte-
ractions, side effects, re-admission and high drop out rates, all of which may fail 
to flatter findings. In addition, there are some important ethical viewpoints when 
including the elderly in clinical studies. Researchers should ensure that the elderly 
are able to understand the purpose of the study and responsibly confirm the patient’s 
cognitive status. It is often a difficult question whether elderly patients with mild 
cognitive impairment should be considered in clinical trials. Many elderly wish to 
inform and discuss the study with relatives before enrolling. Furthermore, visual, 
hearing and cognitive impairments can complicate the patient´s cooperation with 
the clinical staff. Therefore, the researchers must be patient, careful and progress 
slowly with the elderly patients.
However, it is important to increase the the amount of data being retrieved from 
studies on older patients. It cannot be assumed that the benefits to younger patie-
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nts enrolled in trials can be extrapolated to the more frail older patients (Bell et al. 
1987). All elderly patients have age-related physiological changes that affect many 
pharmacological parameters. However, it is not the age, which causes the changes 
in elderly. The general physiological and health conditions are the most important 
factors, which makes the remarkable differences between elderly patients. This 
aspect makes the clinical research work more challenging in the older population.
The number of the patients in primary long-term care increases every year in 
Finland (Finne-Soveri and Tilvis 1998a). Additionally, more elderly patients requi-
re cardiac surgery. One fourth of cardiac surgery patients is aged 75 years or over 
in Helsinki University Hospital in Finland (Suojaranta-Ylinen et al. 2006). The 
investigation reported here has originated from our clinical interest to improve 
pain measurement and postoperative pain management for the elderly patients in 
our clinics. The elderly were involved in these studies willingly and they were very 
interested and well-motivated to cooperate with the researchers. Only seven of the 
cardiac surgical patients (2%) refused to participate in the studies. 
9.2. pain intensity in the elderly (studies i-V)
Pain intensity for all study patients was measured with the VRS, however the RWS, 
the VAS and FPS were also used in studies I-IV. (Table 6-7). The prevalence of pain 
experienced by elderly patients at Rehabilitation Hospital Oulunkylä and at Primary 
Care Hospital Katriina was not determined. Only patients who suffered daily pain 
(study I-II), were recruited for these studies. A cross-national study in Finland, 
Italy and the Netherlands has shown that the prevalence of pain in institutionalized 
elderly people was 57.1% in Finland, 32.2% in Italy and 43% in the Netherlands 
(Finne-Soveri and Tilvis 1998a; Achterberg et al. 2010). A Scandinavian study 
compared pain prevalence, characteristics and clinical correlates among patients 
in long-term care in Denmark, Sweden, Finland and Iceland. The results showed, 
that 22-24% of the residents suffered daily observable pain (Finne-Soveri et al. 
2000). Persistent and chronic pain was highly prevalent with associated negative 
effects on daily function and quality of life. However, our study showed that mild 
chronic pain reduced daily activities less than cognitive dysfunction or depression in 
community-dwelling Finnish elderly (study I). However in the previously performed 
cross-national study, an association between pain and cognitive impairment was 
not found (Finne-Soveri et al. 2000). 
The intensity of pain was mainly mild in our studies for long term care patients 
(studies I-II). They experienced mild pain, although the elderly were given their pain 
killer regularly during the study. It is a well-documented problem in many studies 
that chronic pain is not very well treated in elderly nursing home residents (AGS 
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Panel on Persistent Pain in Older Persons 2002; Allcock et al. 2002).
According to our clinical protocol after cardiac surgery, an analgesic was always 
administered when patients expressed moderate or stronger pain (VRS ≥ 2). Elderly 
surgical patients expressed mostly mild pain at rest, but they reported moderate 
pain after coughing (study III). However, the incidence of the moderate or strong 
pain was momentarily high (40 %) before the administration of analgesic medica-
tion in studies IV-V, despite a clinical protocol for pain treatment. This finding is 
similar to a previous investigation, which found that the intensity of cardiac surgical 
pain fluctuated between moderate to severe pain (Meehan et al. 1995; Ferguson 
et al. 1997; Yorke et al. 2004). This indicates that pain management still requires 
improvement for issues such as more precise pain assessment, the timely admi-
nistration of opioids and the better communication of pain experience between the 
health care professionals and the patients.
In this study, the pain intensity of the elderly was strongest during the first 
three postoperative days after surgery (study III). Correspondingly, the consump-
tion of opioids was as highest during same time period on the first three days after 
cardiac surgery in study V, which was similarly observed by Müller et al. (Mueller 
et al. 2000). 
9.3. pain measurement in the elderly (studies i-V)
The present studies I-III evaluated the pain measurement tools in Finnish elderly 
patients. These studies showed that all four scales (VRS, VAS, RWS, and FPS) are 
reliable and valid pain tools for assessing chronic and acute pain in Finnish elderly 
people. However, the VRS was the most applicable and the most sensitive pain 
scale in our clinical settings in demented elderly patients and in cognitively normal 
elderly after cardiac surgery. Recently, the VRS and RWS have been reported to 
be the best pain measurement scales in Finnish elderly patients with hip fracture 
or other lower limb trauma (Leino et al. 2011). Thus, the results of this study are 
comparable with our findings, which indicated that the RWS is also an applicable 
pain scale for elderly patients after cardiac surgery (study III). Comparatively, Li et 
al. have investigated postoperative pain assessment with three pain intensity scales 
in Chinese elders. The Iowa Pain Thermometer (IPT) was the most practical choice 
based on patients’ preference (Li et al. 2009). Their comparison of four pain scales 
in Chinese adults showed that the FPS-R appeared to be best assessment, followed 
by the NRS and the VDS (Li et al. 2007). Although the FPS has been reported in 
other studies as reliable and valid for older adults (Herr et al. 1998; Taylor and 
Herr 2003; Kim and Buschmann 2006), in our studies the FPS was not an ideal 
tool for pain assessment in Finnish elderly patients; nor was the VAS, which ap-
76
peared to be more unreliable than the VRS and RWS (studies II-III). Therefore, the 
evaluation of the pain scales should be researched for validity across cultural and 
linguistic groups. Culture influences how each person experiences and responds to 
pain, including how and when to request treatment (Melzack 1975; Melzack 1987; 
Campbell et al. 2005; Dworkin et al. 2009). 
Our studies also confirm that the VAS, typically regarded as the gold standard 
of pain measurement, was not considered to be the best choice in Finnish elderly 
patients, including those with mild-to moderate impairment and postoperative de-
lirium and confusion. The VRS had a good profile with low error rates compared to 
the VAS in studies II-III. The difficulties with the use of the VAS among the elderly 
have also been documented previously in the other studies (Gagliese et al. 2005; 
Hadjistavropoulos et al. 2007; Leino et al. 2011). However, Breivik et al published 
a report where the four-point VRS seemed to underestimate intense pain when 
compared to the VAS (Breivik et al. 2000). 
Although many new pain scales have been developed and numerous clinical 
pain research works have been published on demented patients (Fuchs-Lacelle and 
Hadjistavropoulos 2004; Graham et al. 2004; Pautex et al. 2005; Herr et al. 2006a; 
Herr et al. 2006b; Pautex et al. 2006; Hadjistavropoulos et al. 2007; Kaasalainen 
2007; Shega et al. 2007; Breivik et al. 2008; Fuchs-Lacelle et al. 2008; Haasum 
et al. 2011) or the elderly after non-cardiac surgery, many practical problems re-
main regarding assessment and documentation of acute or chronic pain in elderly 
patients in primary care and in the immediate  postoperative phase after surgery 
(Aubrun 2005; Gagliese et al. 2005; Aubrun and Marmion 2007). The results of 
study II clearly demonstrated that the VRS is useful in cognitively normal elderly 
and demented Finnish patients (MMSE  ≥ 17). Approximately 62% of the severely 
demented patients with the lowest MMSE (< 10) were able to express their pain 
intensity with the VRS. Previous studies have reported similar findings, in that the 
VRS is a practical self-reporting assessment tool to measure pain in cognitively 
impaired patients (Closs et al. 2004; Hadjistavropoulos et al. 2008).
Study III may be the first research ever to evaluate and compare the pain sca-
les in elderly patients after cardiac surgery. The VAS is the most commonly used 
tool for the assessment of pain in the routine clinical setting and scientific work, 
although the measurement of pain with VAS has been validated poorly, for examp-
le in elderly cardiac surgical patients (Mueller et al. 2000; Lahtinen et al. 2002; 
Rapchuk et al. 2010). The findings presented here indicate that the VRS is a more 
reliable pain scale than the VAS for use after cardiac surgery. The number of suc-
cessful pain measurements with the VAS was 24% lower compared to the VRS. The 
reasons for the poor success rate with the VAS pain measurements were related to 
postoperative confusion, delirium, and the deep sedation seen in elderly patients. 
Furthermore, a higher age has been associated with a high frequency of failure rates 
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for the use of the VAS (Gagliese and Katz 2003; Fassoulaki et al. 2005; Gagliese 
et al. 2008; Leino et al. 2011). 
The choice of the pain assessment tools in study IV was based on the results 
of studies II and III, where the VRS and the RWS were the best tools for chronic 
pain measurement in cognitively impaired and for postoperative pain measurement 
in Finnish elderly. However, the results of study IV indicated that the elderly had 
considerable difficulties in expressing their pain after cardiac operations by using 
the visual RWS scale, although the RWS was initially developed for measuring the 
intensity of postoperative pain in the recovery room in Finnish patients who recei-
ved general anaesthesia (Tigerstedt and Tammisto 1988). Also, the RWS has been 
used for postoperative pain measurement in Finnish elderly orthopedic patients 
(Silvasti and Pitkänen 2001). It remains speculative as to why the elderly patients 
did not manage to use the visual pain scales during the early postoperative period 
after cardiac surgery. Perhaps, the influences of anaesthesia agents as well as opi-
oids and CPB may impair the ability to interpret the visual pain scales just after 
tracheal extubation. In this respect, it was probably logical to measure the pain 
intensity only with the VRS in study V.  
New findings from these studies demonstrated that the VRS might be a good 
choice to measure acute pain in cognitively normal elderly and chronic pain in 
cognitively impaired elderly. Both cognitively normal elderly after cardiac surgery 
and cognitively impaired elderly with chronic pain have difficulties in expressing 
their pain with visual pain scales (i.e. the VAS, the RWS, and the FPS). 
9.4. the seVerity and inCidenCe of pain estimated by 
the nurses in elderly patients
In study II, the incidence and severity of pain estimated by the nurses did not cor-
relate with the patients’ pain intensity as measured with the four tools. This find-
ing indicates that the communication of pain experience between the cognitively 
impaired patients and nursing staff remains challenging. The demented patients 
may be unable or unwilling to express their pain. Nursing staff have a hectic day 
schedule and pain control can become a secondary consideration to the greater vol-
ume of nursing work. Additionally, other researchers have reported that the health 
care professionals tend to underestimate pain in demented patients (Pautex et al. 
2005), as well as after cardiac surgery (Watt-Watson and Stevens 1998). Based on 
the results of study II, the VRS appears to be a good choice for the clinical assess-
ment of pain in the elderly. Pain control should be performed at regular time points 
and individually, when the patient is likely to suffer from pain and when the patient 
complains of pain. In addition, pain should always be measured before and after 
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the administration of pain medication, mobilization, physiotherapy, during daily 
activities and the nursing procedures which may cause pain. It is very important 
to know the intensity of patients’ pain over time instead of knowing only whether 
pain is present or not (Cleeland and Ryan 1994). Nowadays, most hospitals have 
an Acute Pain Services (APS). This organization with pain nurses and anesthesi-
ologists have improved postoperative pain management. They are also responsible 
for educating for health care staff involveded in postoperative care.  The intensity 
of postoperative pain in middle-aged patients on the ward has been reported to 
decrease by the implementation of a nurse-based pain service with an acute pain 
nurse (Salomäki et al. 2000).
9.5. effeCt of fentanyl in the elderly  
after CardiaC surgery 
In study IV, at the end of the cardiac surgery performed under anaesthesia with 
intravenous fentanyl and an inhalational agent, the plasma concentration of fen-
tanyl was higher after the discontinuation of fentanyl infusion and two hours later 
in elderly patients in comparison with those of younger adult patients. The current 
emphasis on fast recovery, early tracheal extubation and a short stay in the ICU 
demands a great precision in administering fentanyl in the elderly. Fentanyl is 
still widely used as a potent intraoperative analgesic agent with hypnotic drugs for 
non-cardiac and cardiac surgery in all aged patients (Ahonen et al. 2000; Hudson 
et al. 2002; Myles et al. 2002; Silbert et al. 2006). The first studies of the pharma-
cokinetics of fentanyl in the elderly were published by Bentley et al., and Scott and 
Stanski, in the early 1980s; who described that some of fentanyl´s pharmacokinetic 
variability with respect to clearance could be aged related (Bentley et al. 1982), al-
though this conclusion has not been verified (Scott and Stanski 1987; Singleton et 
al. 1988). The current investigation indicates that the risk of fentanyl accumulation 
after continuous infusion is higher in elderly than in middle aged patients. This 
result is consistent with previous studies that showed accumulation of fentanyl 
after buccal administration in healthy volunteers (Clark et al. 2004; Darwish et 
al. 2008). Recent studies found that patients have better and faster recovery after 
cardiac surgery when they receive morphine as compared with fentanyl. Fentanyl 
presents no benefits over morphine in terms of the duration of tracheal intubation, 
length of stay in the critical care unit, or period of hospitalisation (Myles et al. 
2000; Murphy et al. 2009). In addition, it has been published that, in comparison 
to fentanyl, morphine improves myocardial function and reduces inflammatory 
markers after cardiopulmonary bypass (Murphy et al. 2007). The future of fentanyl 
in cardiac anaesthesia can only be resolved with time and more research. To assess 
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its potential, larger, randomized studies are required, where elderly patients and 
patients undergoing more demanding surgeries are included.
9.6. effeCt of oXyCodone and postoperatiVe pain 
management in the elderly after CardiaC surgery 
There was no difference in the plasma concentrations of oxycodone between eld-
erly (≥ 75 years) and middle-aged (≤ 60 years) patients after oxycodone doses 
(0.05 mg/kg i.v.). However, the elderly retained painlessness for longer and were 
more deeply sedated after the second bolus. The results presented here indicate that 
the elderly are more sensitive to the analgesic action of oxycodone and the clear-
ance of oxycodone is slower in the elderly. There are a relatively small amount of 
studies into the use of oxycodone in the elderly; Villesen et al. have demonstrated 
the pharmacokinetics of morphine and oxycodone following intravenous admin-
istration to elderly patients after hip surgery (Villesen et al. 2007). They reported 
that the elderly had a great variability in the individual pharmacokinetic parameters 
for both opioids, however they did not find any changes in the pharmacokinetic 
parameters of morphine and oxycodone following intravenous administration in 
elderly patients compared with younger healthy volunteers. Additionally, Kaiko et 
al. did not document any significant difference in the AUC of a single 20 mg oral 
dose of controlled-release oxycodone between young (< 45 years) and older (> 65 
years) patients (Kaiko et al. 1996). Similar findings have been published by Cher-
rier et al. (Cherrier et al. 2009). 
9.7. opioids side effeCts in the elderly  
after CardiaC surgery
9.7.1. oVer sedation, Confusion, and delirium
The results of studies III-V indicate that old age is a risk factor for over sedation, 
confusion, and postoperative delirium after cardiac surgery. Acute changes in cogni-
tion and attention after cardiac surgery are a well-documented multilateral problem. 
Pre-existing cognitive dysfunction is one of the strongest predictors of the devel-
opment of postoperative delirium. The incidence of postoperative delirium varied 
from 3 to 73% depending in the type of cardiac surgery (Sockalingam et al. 2005). 
Prevention of delirium is important especially in the elderly. The optimization of 
analgesics and pain control has a marked impact on patient comfort and prevention 
of confusion and delirium (Herrick et al. 1996). The findings of study IV indicated 
80
that the elderly were more sedated and had less pain after oxycodone doses during 
the early postoperative period after extubation. Study V, suggested that the opioid 
sparing-effect of pregabalin decreased postoperative confusion in elderly patients 
on the first postoperative day after extubation. Based on these observations, it is 
important to avoid the high doses of opioids in elderly patients. The stricter clinical 
guidelines and protocols for regular pain measurement and the assessment of the 
level of sedation could lead individual opioid dosing in elderly patients. The result 
might be less oversedation, confusion and delirium postoperatively in the elderly.
9.7.2. postoperatiVe nausea and Vomiting
The prevalence of nausea and vomiting (PONV) in elderly patients varied from 34% 
to 37% in studies IV and V. In earlier studies, the overall incidence of PONV in 
patients undergoing cardiac surgery  was higher  (45-50%) than in our investigation 
(Grebenik and Allman 1996; Woodward et al. 1999). One risk factor for PONV is age 
under 60 years (Kogan et al. 2003); our results are in agreement with that finding.
9.8. the opioid sparing effeCt of pregabalin in elderly
This was the first study where the opioid sparing effect of pregabalin was inves-
tigated in elderly patients after cardiac surgery. Our findings indicated that the 
administration of pregabalin reduced the incidence of postoperative confusion on 
the first postoperative day, but pregabalin increased the time to extubation. In ad-
dition, pregabalin-treated elderly had less pain in early postoperative period and 
during movement at three months after cardiac surgery.
Several studies have demonstrated the opioid-sparing effect of pregabalin in 
middle aged patients after non-cardiac surgery (Agarwal et al. 2008; Freedman 
and O’Hara 2008; Bockbrader et al. 2010 Burke and Shorten; 2010 Buvanendran 
et al. 2010). Our finding was also clear: the total parenteral oxycodone during the 
16 hours following extubation was reduced by 44% and the total consumption of 
oxycodone from extubation to the end of the fifth day decreased by 48% in the 
pregabalin group. 
Multimodal or balanced analgesia, the combination of non-opioid analgesic to 
opioid, has been proposed to decrease opioid like morphine or oxycodone con-
sumption and to improve postoperative pain management after surgery (Kehlet 
and Dahl 1993). However, most studies have not documented a decrease in the 
adverse effects of opioids related to the reduction in postoperative opioid require-
ment (Remy et al. 2005). Marret et al. published a meta-analysis, which showed 
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the benefits of combining NSAIDs and morphine to decrease opioid-related side 
effects such as PONV and sedation but not pruritus, urinary retention, or res-
piratory depression (Remy et al. 2005). Our result might demonstrate that the 
opioid-sparing effect of pregabalin reduces postoperative confusion on the first 
postoperative day. On the contrary, previous studies indicated that the administra-
tion of pregabalin was associated with a higher risk of early postoperative sedati-
on and confusion after orthopedic surgery (Mathiesen et al. 2008; Buvanendran 
et al. 2010) and increased the incidence of the adverse effects after laparoscopic 
hysterectomy (Jokela et al. 2008b). 
The target of multimodal analgesia is not only the improved quality of postopera-
tive pain management, but it is also important to reduce opioid-related side-effects 
(Kehlet and Dahl 1993). Pregabalin has been shown to reduce the consumption of 
opioids and pain intensity and to improve postoperative analgesia, but the real cli-
nical benefit is still unclear in a multimodal acute postoperative analgesia. There are 
also some studies where gabapentinoids have not been beneficial for postoperative 
pain management (Jokela et al. 2008a; Peng et al. 2010; Rapchuk et al. 2010). 
Pregabalin is a new-comer in a multimodal analgesia that is yet to play a central 
role in postoperative analgesia. 
9.8.1. the side-effeCts of pregabalin in elderly
The use of pregabalin has rapidly become a popular analgesic for acute and chronic 
pain in the elderly. Unfortunately, most studies on pregabalin have been performed 
in middle-aged patients or in healthy volunteers. Moreover, pregabalin is considered 
to be a safe drug, although it has remarkable central nervous system-related side-
effects for which the mechanism of action is not clear. Pregabalin may have some 
significant pharmacodynamic interactions. An additive effect of pregabalin with 
oxycodone has been reported. Also, pregabalin potentiates the effects of lorazepam 
(Ben-Menachem 2004). In the current study, one patient in the pregabalin group 
required naloxone for respiratory depression after extubation in the ICU. 
In two case studies, patients demonstrated clinical evidence of worsening heart 
failure and weight gain after pregabalin administration (Murphy et al. 2007; Page 
et al. 2008). Possible, interaction with calcium channels may explain the deterio-
ration in heart failure. Furthermore, direct renal effects promoting salt and water 
retention may also be responsible (Murphy et al. 2007). In this study, patients with 
left ventricular failure or renal insufficiency before the operation were excluded; 
no patients in the pregabalin group developed heart failure after the operation. 
Pregabalin can cause nervous system-related adverse effects such as dizziness and 
somnolence. In this study, all of the patients with stroke were in the pregabalin 
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group and the incidence of stroke was 8.6%. Stroke incidence after cardiac surgery 
varies from 1.5 to 9% (Murkin 1999; McKhann et al. 2006; Parlow et al. 2010). 
Thus, the finding of incidence of stroke in the present study is comparable with 
previous studies. Nevertheless, the observation of three strokes in the pregabalin 
group must be considered seriously.
9.9. postoperatiVe pain in elderly after  
CardiaC surgery
This is the first study to have indicated decreased pain intensity three months 
after cardiac surgery due to perioperative treatment with pregabalin. Periopera-
tive treatment with gabapentioids has already been shown to reduce the incidence 
or severity of chronic postsurgical pain in middle-aged patients after non-cardiac 
surgery (Fassoulaki et al. 2005; Fassoulaki et al. 2006; Buvanendran et al. 2010). 
Risk factors for chronic pain after cardiac surgery include a poor acute pain control 
and a younger age (Bruce et al. 2003; Kehlet et al. 2006; Lahtinen et al. 2006; 
Taillefer et al. 2006; Katz and Seltzer 2009). The incidence of pain three months 
after surgery was low in this study, being 16% in the placebo and 4% in the prega-
balin group. However, the present study was not powered to detect differences in 
the incidence of chronic pain after surgery. Given their obvious effectiveness, the 
gababetinoids may play a future role as a component of preemptive multimodal 
acute pain treatment to increase the effectiveness of the other analgesics and they 
might also prevent the development of chronic pain.
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Limitations of the present series of studies
10. limitations oF tHe Present series  
 oF studies
The results of these studies must be interpreted with caution due to some limitations.
10.1. sample size, randomization, and power analysis 
in studies i-V
The study group sample size in the first two studies was small. This prevents the 
establishment of any conclusions regarding the reasons behind our obtained signifi-
cant correlations. Power analysis was not done in studies I-II, whilst studies I-III 
were not truly randomized. The patients of studies I-II were chosen at random based 
on clinical aspects. Patients were allocated to study groups according to the heart 
operation number of the clinical computer list in study III. A significantly larger 
patient population would have been needed for reliable evaluation of confusion, 
nausea, vomiting, or the incidence of postoperative pain in study V.
10.2. pain measurement in studies i-iii
The correlations between the different pain tools have to be interpreted with cau-
tion because VRS is a verbal tool and the others are visual tools.
10.3. determination of fentanyl and oXyCodone Con-
Centrations in plasma 
The lower limits of quantitation were set at 1.0 and 2.0 ng/ml for fentanyl and 
oxycodone, respectively. Probably, due to very low plasma concentrations, a greater 
sensitivity and the accurary of the determination method for the opioids would have 





Despite the development of many pain measurement tools in the last twenty years, 
poor pain management in the elderly remains an issue. Furthermore, there is no 
universal pain scale that is suitable for all elderly patients. Therefore, pain scales 
should be evaluated and validated in different types of patients and in different 
cultures in the future and the most reliable pain measurement tool should be used 
to relieve pain in a more specific manner. Additionally, the evaluation of pain scales 
should be a continuous process in the clinical setting. This study suggests that the 
VRS is appropriate for the assessment of pain intensity of Finnish elderly, even 
when their cognition is mildly or moderately impaired. 
Poor documentation of pain intensity before and after the administration of pain 
medicine remains a clinical problem in pain management. As long as the recording 
of pain intensity is incomplete, the quality of pain treatment is insufficient even 
when the pain scale is validated. In the future, out-hospital patients could potenti-
ally self-report their pain intensity, electronically in real time, to the hospital pain 
monitoring system and database, which could automatically or semiautomatically 
adjust pain treatment. However, the least healthy elderly will always need the nursing 
staff, who assess and record their pain systematically using validated pain scales. 
To improve the clinical management of pain, it is important to implement further 
quality assurance efforts. Pain intensity and individual therapeutic goals should be 
defined for each elderly patient. In addition, particular attention must be given to 
individual dosing of opioids in elderly surgical patients, who often need a smaller 
amount for adequate analgesia than middle-aged patients.
The elderly population consumes the greatest proportion of prescribed medici-
nes in Western Europe. However, most clinical pharmacological studies have been 
performed in healthy volunteers or middle-aged patients. Aging causes physiological 
changes that have an influence on the pharmacokinetics and the pharmacodynamics 
of drugs, increasing the risk of side effects and drug interactions. In principle, a 
new drug may cause unexpected effects in the elderly. Therefore, in the future, the 
elderly should be included in clinical trials more often. 
This study indicates that pregabalin might be a new alternative as analgesic for 
acute postoperative and chronic pain management in the elderly. Its clinical role 





1.  Cognitive dysfunction and depression were associated with reduced daily 
activities more than chronic pain in home-dwelling elderly people.
2.  The scoring of visual pain measurement tools with RWS, FPS and 
VAS seems to be feasible in elderly patients with a normal cognitive 
dysfunction. VRS appeared to be applicable in the elderly with a clear 
evident cognitive dysfunction (MMSE < 17). Immediately after cardiac 
surgery, VRS proved to be the most feasible pain scale, followed by RWS. 
The usefulness of VRS for pain assessment in the temporarily confused 
elderly patients after cardiac surgery and demented patients was shown 
in this study. The VRS is an easily applicable pain measurement tool for 
regular assessment in the elderly at the various levels of health care from 
acute postoperative care to the geriatric department of a primary care 
hospital.
3.  Elderly patients after cardiac surgery had less pain and they needed 
oxycodone hydrochloride boluses more infrequently and were more 
deeply sedated than the middle-aged cardiac surgery patients. It is likely 
that elderly patients are more sensitive to opioid effects. Therefore, 
particular attention needs to be paid to the dosing of opioids and the 
regular pain assessment after pain treatment in elderly surgical patients, 
who often need smaller amounts for adequate analgesia than middle-aged 
patients.
4.  Pregabalin reduced oxycodone consumption, pain and postoperative 
confusion after cardiac surgery in elderly patients. Pregabalin may be a 
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